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Shareholder investments declined in Jordanian pharmaceutical business expansion 
between 2007 and 2014, which included a reduction in the supply of essential medicines 
in the Middle East and North Africa (MENA). The purpose of this qualitative multiple 
case study was to explore effective applications of expansion strategies ‎to satisfy demand 
in the MENA markets among Jordanian generic pharmaceutical companies’ managers. 
The conceptual framework for this study was based on the transformational leadership 
theory‎and‎stakeholders’‎theory. The purposive sample consisted of 4 chief executive 
officers and 8 managers from Jordanian pharmaceutical companies who practiced the 
expansion strategy in the MENA for more than 10 years. The data were triangulated from 
semistructured interviews and cash flow financial statements. Interpretation summaries of 
the‎participants’‎answers were applied for the member-checking process to bolster the 
trustworthiness of interpretations. Four themes emerged from the analysis process: 
leaders’ adaptability‎to‎change,‎financial‎capacity‎and‎stability,‎stakeholders’‎business‎
awareness,‎and‎managers’‎engagements‎and‎knowledge. The findings may provide the 
generic pharmaceutical business leaders and managers with increased growth capabilities 
for catalyzing beneficial positive capacity expansion strategies. The subsequent 
expansion could provide adequate, affordable, and accessible medications for effecting 
social changes by fighting disease in remote and low-income MENA communities.
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Section 1: Foundation of the Study  
Demand for pharmaceuticals is increasing in populated regions of the world, 
especially in low-income parts of the Middle East and North Africa (MENA) (World 
Health Organization, 2014). Generic pharmaceutical industries in the middle-income 
regions of the MENA region provided solutions for the pharmaceutical availability, in 
which effective strategies implementation for the pharmaceutical business expansion 
contributed to profits generation in the targeted MENA regions (Cameron, Mantel-
Teeuwisse, Leufkens, & Laing, 2012). Generic pharmaceutical industry leaders in Jordan 
are developing business systems according to international standard requirements and 
they are expanding in developed and developing regions of the world (Sharabati, Naji 
Jawad, & Bontis, 2010; Sharabati, 2013). Expansions strategies among successful leaders 
rely on the capabilities to gain value and respond to customers in competitive business 
models that will satisfy demands of low-income people in MENA and attain profitability 
for pharmaceutical industry shareholders (Dylst, Vulto, Godman, & Simoens, 2013).  
Background of the Problem 
Professionals and practitioners have focused attention on the competitive 
advantages of pharmaceutical markets with regard to leveraging profitability and 
discovering business opportunities (Ahmad, Khoso, Zubair, & Ahmed, 2014; Dixit & 
Yadav, 2015; Srivastava & Prakash, 2014). Professionals and practitioners from 
developed countries applied expansion strategies based on gained and practiced 
marketing knowledge, organization systems, and production expertise to form 
competitive advantages for expanding the pharmaceutical business in different regions in 
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the world, including MENA (Esper, Ellinger, Stank, Flint, & Moon, 2010). Generic 
pharmaceutical industry leaders developed industrial systems that matured through 
adopting developed processes from product originators to comply with marketing 
requirements in the developed regions of the globe (Pollock, 2014). Emerging economies 
are opportunities for generic pharmaceutical industries to explore because of (a) 
increasing demands for pharmaceuticals, (b) emerging chronic diseases, (c) 
transformation to western fast food consumer style of leaving, and (d) international 
regulation enforcement (African Development Bank and UN Development Program, 
2014). Commercialization of generic pharmaceutical products, know-how expertise, and 
systems in emerging economies are expanding business models that leaders are using to 
satisfy the demands and generate business opportunities for the developing industrial 
systems (Daems, Maes, Mehra, Carroll, & Thomas, 2014; Mastorakis & Siskos, 2016; 
Vecchiato, 2012). 
Researchers have addressed the scientific background requirements for managers 
and their technical talents, educational levels, technical pharmaceutical skills, and 
experiences requirements to implement pharmaceutical expansion business strategies 
(Candi, Ende, & Gemser, 2013; Landry, Amara, Cloutier, & Halilem, 2013). Authors in 
the current literature suggested further studies and research to fill the gap in knowledge 
regarding the managerial and administrative competencies and perceptions of 
pharmaceutical managers to implement expansion strategies in the pharmaceutical 
business (Martín-Rojas, García-Morales, & Bolívar-Ramos, 2013; Teirlinck & Spithoven, 
2013). Authors of pharmaceutical expansion business models have discussed 
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intertechnology transfer, licensing, and franchising and have focused on aspects related to 
internal developed business model applicability to legalization, human resources, 
cultures, and infrastructures requirements (Casado & Peláez, 2014; Mehralian, Rasekh, 
Akhavan, & Ghatari, 2013; Sharabati et al., 2010). In addition, the regulatory codes for 
the‎management‎qualification‎for‎“safe,‎pure,‎and‎effective”‎pharmaceutical‎product‎
manufacturing enforced the scientific, technical, and engineering skills (Food and Drug 
Administration [FDA], 2001). Exploring the combination effectiveness of FDA 
requirement and managers perceptions in pharmaceutical business strategy 
implementation is critical for advancing business knowledge. In this study, I explored 
implementation of successful business expansion strategies related to manager 
perceptions in the Jordanian pharmaceutical industry. 
Problem Statement 
Shareholder investments in Jordanian generic pharmaceutical business expansion 
strategies ‎declined during the last decade (Qader, Nour, & Hussein, 2013; Rafols et al., 
2014), which affected ‎availability of medicine in the MENA region (UN 
Millennium ‎Development Goals, 2014). In 2013, generic pharmaceutical business leaders 
failed to ‎develop a business expansion strategy to satisfy demands for $26.2 billion of 
supplies of ‎essential medicines for developing countries in the MENA region (UN 
Millennium ‎Development Goals, 2014). The general business problem was that some 
leaders in generic ‎pharmaceutical organizations in Jordan lack management strategies for 
developing business ‎expansion to meet demands for generic pharmaceuticals for the 
MENA markets. The ‎specific business problem was that some Jordanian 
4 
 
pharmaceutical ‎managers ‎lack effective applications of expansion strategy ‎to satisfy 
demand in the MENA markets. 
Purpose Statement 
The purpose of this qualitative descriptive multiple case study was to explore 
effective application of expansion strategy among Jordanian pharmaceutical managers ‎to 
satisfy the demand in the MENA markets. I interviewed four chief executive officers 
(CEOs) and eight managers from generic pharmaceutical companies in Jordan who 
practiced and succeeded in applying expansion strategies in the MENA region. I selected 
participants purposely from Jordanian pharmaceutical managers who were experienced in 
the professional application of expansion strategies in the MENA markets. My findings 
may improve knowledge and efficacy of strategies and practices for expanding business 
in the MENA region to satisfy potential market demands. The remote MENA 
communities lack adequate pharmaceutical supplies and suffer from different diseases 
that the generic essential medicines supplies could help resolve in communities (UN 
Millennium ‎Development Goals, 2014). These communities are potential stakeholders 
who could benefit by increasing generic medical supplies, thereby meeting both 
physician and patient needs for increasing availability and decreasing costs of generic 
pharmaceuticals to fight diseases. 
Nature of the Study 
I proposed the qualitative research method for addressing the purpose of this 




environment by direct contacts and observations. Quantitative and mixed-methods 
formats were not appropriate for my study because the collection of quantifiable data of 
different variables within hypothetical guided approaches is not applicable for exploring 
perceptions of individuals (Zivkovic, 2012). Therefore, I used the qualitative method and 
explored effective expansion strategies that Jordanian pharmaceutical managers applied 
to satisfy demands in the MENA markets. 
Qualitative research designs include ethnography, narrative, and 
phenomenological formats for focusing on culture, ethnic, and lived experiences of 
participants (Denzin & Lincoln, 2011). The application of phenomenological design 
includes similarities between participants within the affected phenomenon (Yadav, 2013). 
I explored, analyzed, interpreted, and addressed different‎companies’‎strategies,‎visions,‎
and practices to‎address‎my‎study’s‎purpose. I did not use a phenomenological study 
design because of the variation involving strategy implementation among companies, 
CEOs, and managers.  
Industrial entities comprise multicultural employees, and the purpose of this study 
was to explore successful strategies for business expansion including different 
communities in the MENA region and not cultural implications, which eliminates using 
an ethnographic study. Individual experiences of storytelling were not appropriate for 
conducting this study because of the‎study’s multiple exploration nature among many 
CEOs and managers, which excludes the narrative study. Case study researchers can 




the participants’‎responses and to code and theme meanings (Collins & Cooper, 2014). 
Similarly, the case study approach allows further understandings through additional 
exploratory questions to identify and characterize the core concept that the participants 
experienced (Yin, 2014). The qualitative multiple case study design was, therefore, an 
appropriate design for my study. 
Research Question 
The central research question was: What strategies do Jordanian pharmaceutical 
managers apply for effective business expansion ‎to satisfy the demand in MENA 
markets? 
Interview Questions 
The interview questions I used were as follows: 
1. What strategies do you use for expanding generic pharmaceutical capacity 
for the MENA customers? 
2. What challenges did or do you face in implementing the business expansion 
strategies for this organization? 
3. What are core business processes that improve expansion strategy in this 
organization? 
4. What are the principal barriers you faced or are facing in implementing the 
expansion strategy? 
5. How do you communicate and address the barriers with subordinates 
working in expansion strategy?  
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6. How did or do you address the principal barriers solutions or overcome in 
your expansion strategy? 
7. How do you evaluate expansion strategies implementations? 
8. What‎are‎managers’‎contributions‎to‎expansion‎strategies? 
9. How are managers’‎capabilities‎supporting expansion strategies in MENA 
region? 
10. What are supports you needed or need from shareholders to address the 
expansion strategy? 
11. How do you align the expansion strategy with the production capacity 
design? 
12. What other information, not addressed in the interview questions, are 
pertinent to your development and implementation of expansion strategies 
for generic pharmaceuticals in MENA region? 
Conceptual Framework 
I applied the transformational leadership theory as a conceptual framework for 
this study. In addition to transformational leadership theory, stakeholder theory was an 
appropriate element of my conceptual framework because of the affected groups 
inclusion in the business expansion strategy. The following sections include my 
conceptual framework for addressing the expansion strategy mechanisms for this study.  
Transformational Leadership Theory 
In 1978, Burns introduced a definition of transformational leadership to address 
the process for leveraging mutual benefits for leaders and followers through morality and 
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motivations (Northouse, 2013). Values are tools for transformational leaders that address 
motives for identifying and achieving mutual objectives (Antonakis & House, 2014). 
Leaders must equip followers with knowledge and skills to understand and achieve the 
strategies objectives. In this study, I identified the expansion strategies for production 
capacities stemming from‎transformational‎leadership’s‎effectiveness in pharmaceutical 
industries in Jordan. I explored the‎values‎of‎leaders’‎contributions‎to‎enhancing‎
commercialization processes through the lens of the transformational leadership. 
Stakeholders’ Theory 
Freeman’s (2010) definition of stakeholders depended on organizations’‎
interactions in business environments, which include parties from internal and external 
surroundings of the organization. Freeman extended the affected parties to include 
governments, competitors, suppliers, employees, and regulatory parties. The organization 
activities involve changes, benefits, and developments, in which social interactions 
consequences affect the organization’s strategic performance (Miles, 2012). Freeman 
focused on identifying the benefiting and affected parties or individuals. In this study, I 
applied stakeholders’‎theory‎to the Jordanian pharmaceutical companies’ expanding 
strategies in the MENA region, which Kazadi, Lievens, and Mahr (2015) posited as an 
effective focus strategy for pharmaceutical companies’‎potential stakeholders. Valverde 
(2013) suggested increasing stakeholder’s‎benefits‎by using corporate transparency, 
complying‎with‎regulations,‎and‎raising‎stakeholders’‎awareness‎of‎the‎internal capacities 
development requirements including external capacities for market access that involved 
expansion strategies. In addition, the primary stakeholders in the expansion strategies are 
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the investment sectors and the shareholders, for which return on investment and 
increasing revenues are important expansion strategies objectives among pharmaceutical 
organizations (Tripathy & Prajapati, 2014). 
Operational Definitions 
I used the following terms and definitions in this study: 
Competitive advantage:‎Competitive‎advantage‎is‎the‎reasons‎for‎customers’‎
preferences over other competitors and results in increasing sales, benefits, and retention 
of customers (Bartlett & Ghoshal, 2013; Teixeira & Werther, 2013).   
Expansion strategy: Expansion strategy is the application of procedures and 
operations to achieve‎calculated‎growth‎that‎differs‎from‎the‎previous‎organization’s‎
performance (Scott & Bruce, 1987). 
Generic pharmaceutical: This term refers to a copied pharmaceutical product 
from an originator after expired patent protection, which follows and possesses the 
regulatory requirements at a lower price than the originator (Danzon, Mulcahy, & Towse, 
2015).  
Good manufacturing practice (GMP): Good manufacturing practice (GMP) is a 
set of rules and regulations for pharmaceutical industries to follow during pharmaceutical 
product formulation, processing, production, and packing according to the U.S. Federal 
Food, Drug, and Cosmetic Act (Food and Drug Administration [FDA], 2001). 
Managerial competency: This term refers to a group of skills, experiences, and 




Organization’s performance: This refers to a multidimensional set of values, 
targets, economic factors, social implications, and business objectives that researchers 
apply‎to‎determine‎the‎effectiveness‎of‎the‎intentions‎of‎organizations’‎activities‎
(Camisón & Villar-López, 2014; Dess & Robinson, 1984). 
Return on investment (ROI): Return on investment (ROI) is the outcome of 
benefits or cost from the implementation of the specific process, strategy, product, or 
service that stockholders, leaderships, managers, or employees view as primary factor for 
evaluating‎organization’s‎performance‎(McNulty,‎De‎Cieri,‎&‎Hutchings,‎2013). 
Talent management: This term refers to a set of procedures, factors, and methods 
that the human resource manager uses to attracting, recruiting, and retaining talented 
employees to achieve the objectives (Festing & Schäfer, 2014). 
Assumptions, Limitations, and Delimitations 
Assumptions 
Assumptions are the researcher’s anticipated issues in the research that the 
researchers cannot control (Podsakoff, MacKenzie, & Podsakoff, 2012). I assumed that 
participants in this study reflected reality and were honest in responding to the interview 
questions. Participants agreed to participate in this study voluntarily until the data 
collection method reached the saturation point. My selected analysis method of the data 
and sample size were adequate to define themes. I assumed that my literature review 
supported the participants’ responses for the research demography. I assumed that my 
findings might add to professional knowledge for leveraging the institutional competence 




Limitations are weaknesses of the research (Podsakoff et al., 2012). Participants 
in this study were from a scientific background with professional management positions 
in the pharmaceutical industry; therefore, there is a possibility of misinterpretation of the 
questions with administrative or business nature. The conceptual research framework 
includes the research parameters and might not include all reflections of participants’‎
responses to the interview questions. The small sample size may make it difficult to 
generalize the findings (Yin, 2014).  
Qualitative research methods include limitations by the nature of the study that 
includes researcher explorations of the meanings but not exact experimental designs of 
participants’ practices and performances (Ercikan & Roth, 2014). In this qualitative 
research study, the exploratory nature implied the limitation of the number of participants 
from implementation perceptions of expansion strategy. Further limitations included the 
participants’‎understandings‎of‎the‎processes‎and‎procedures‎that‎they‎perform‎to‎achieve‎
the strategies for expansion within the routine day-to-day tasks. Therefore, I defined in 
the analysis part the different processes and procedures for contributions to the expansion 
strategies and daily performance tasks, which was limited for each company practices 
according to the perceptions and understandings of the participants and my 
interpretations of the meanings. I used the keywords in context (KWIC) method to 
minimize possible inaccurate interpretations (Leech & Onwuegbuzie, 2008). In addition, 
I applied the member-checking process to confirm my interpretation of the meanings 




The scope of this study included Jordanian pharmaceutical companies. 
Delimitations are areas that are not included in the research objectives (Rusly, Corner, & 
Sun, 2012). My research targeted participants from Jordan only. I requested participants 
with managerial experiences of 5 years and more. Therefore, I did not include managers 
with less than 5 years in positions. The scope of this study focused on the accumulated 
knowledge, experiences, training, and directives among leaders and managers in the 
Jordanian pharmaceutical industry. 
Significance of the Study 
Strategic business expansion for industrial organizations is one of the growth 
factors that stakeholders must address to increase interests in supporting organizational 
changes and increasing financial benefits (Hofmann, Busse, Bode, & Henke, 2014). Ai 
and Brockett (2012) recommended further research to explore strategic business models 
that would develop organizational management awareness to advance business 
expansion. In addition, shareholders and leaders are interested in promoting the social 
changes that the company expansion strategies include through integrated sustainability 
initiatives (Alakent & Ozer, 2014). I included the contribution of my study to business 
practices and the implications for social change.  
Contribution to Business Practice 
Generic pharmaceutical leaders, managers, employees, and other stakeholders 
could benefit from‎my‎study’s‎findings‎regarding successful capacity expansion 
strategies. By applying effective expansion strategies for pharmaceutical products in the 
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MENA region, leaders might increase the efficiencies and effectiveness of the business 
models in terms of collaborations, investments, franchising, venturing, or mergers (Ai & 
Brockett, 2012). Such business models for expansion strategies are long-term profit 
generating practices, which include strengthening branding strategies, targeting new 
markets, and increasing sales. 
Implications for Social Change 
Social changes are ideas, structures, and practices that involve institutional 
developments for individuals or groups in an intersocial environment (Ney & Beckmann, 
2014). In the MENA region, the demands for medication availability are increasing with 
the rise of population, poverty, and prevalent diseases. In 2013, generic pharmaceutical 
producers could not satisfy the demands of $26.2 billion worth of essential medicines 
(UN Millennium Development Goals, 2014). Franks et al. (2014) recognized expansion 
strategies with indication of corporate-cultural social change initiatives as an 
advancement of corporate sustainability. I expect that my findings will provide generic 
pharmaceutical leaders and managers with increased capabilities for catalyzing beneficial 
social changes via capacity expansion strategies. The subsequent expansion could 
provide adequate, affordable, and accessible medications for effecting social change by 
fighting diseases in the remote MENA societies. 
A Review of the Professional and Academic Literature 
The exploration of the expansion strategy in this study includes the leadership 
value creation to motivate followers and enhance performances. Therefore, the 
transformational leadership theory of Burns (1978) was a foundation for this literature 
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review, which I included in the conceptual framework in this study. In this review, I 
included studies in which authors addressed relationships, explorations, and revisions for 
the transformational leadership theory in the expansion strategies implementation. In 
addition, I reviewed published works in pharmaceutical business fields that included 
transformational leadership theory. 
Stakeholder’s‎theory‎was the second foundation of this literature review with 
relation to the conceptual framework‎of‎this‎study.‎The‎application‎of‎Freeman’s‎(2010)‎
concept of stakeholders included beneficiaries from expansion strategy. I related studies 
in this literature review for the expansion strategy that authors addressed to explore, 
quantify, and revise about stakeholders in the business expansion strategies. I reviewed 
the literature for the expansion strategies in the concepts of transformational leadership 
theory‎and‎the‎stakeholder’s‎theory‎from‎pharmaceutical‎published‎business‎works. 
Pharmaceutical leader awareness of expansion strategy benefits and ‎requirements 
include‎development‎and‎direction‎of‎managements’‎efforts‎to‎
implement ‎commercialization processes including marketing and sales (Moors, Cohen, 
& ‎Schellekens, 2014; Sarkees, Hulland, & Chatterjee, 2014). Stakeholders, including 
the ‎shareholders, must‎benefit‎from‎the‎pharmaceutical‎organizations’‎business‎
expansion ‎performance, which enhances leadership direction and improves 
managerial ‎understanding‎of‎the‎stakeholders’‎influence (Kazadi et al., 2015). 
The ‎purpose of this qualitative descriptive multiple case study was to explore 
the ‎effective implementation of expansion strategies that managers in 
pharmaceutical ‎industries in Jordan applied and the effective leadership strategy delivery 
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for a profitable ‎business. These research findings may ‎add or assist leadership’s 
perceptions to improve expansion strategy accomplishments. In addition, the findings 
might identify the business value of the commercialization of the organization ‎systems, 
product sales, and effective business models between Jordan and other emerging 
economies. This ‎section includes a review of the professional and academic literature and 
previously ‎completed works related to the research topic. The discussion covers the 
works that ‎contributed to the conceptual framework: (a) leadership and business 
competitiveness, (b) ‎managers’‎tools‎to‎achieve‎expansion‎strategies,‎(c)‎stakeholders‎and‎
organization ‎performances, (d) active and potential stakeholders, (e) organizational 
systems relations in ‎pharmaceutical industries, and (f) business expansion models in 
pharmaceutical industries. ‎Figure 1 illustrates the flow of the literature review for this 
study.‎ 






























For this literature review, I collected studies from Walden University’s‎library 
database, related articles for expansion strategy, books, and web-based articles from the 
Mendeley Desktop database with Zotero synchronization. In addition, I collected web 
pages and websites from world organizations, pharmaceutical associations, and national 
health organizations. I considered the contents for the topic and organized the materials. I 
searched the articles within the databases to find alignment between the conceptual 
framework and the problem statement and used the most relevant articles for citations. I 
cited 278 articles, of which 257 (i.e., 92%) were from peer-reviewed sources published 
between 2012 and 2016. I developed the literature review using 168 articles. In this 
literature review, I used 156 citations from peer-reviewed articles published within 5 
years from 2016, which is 93% of the total cited articles in the literature review.  
Leadership and Business Competitiveness 
Leaders leveraged the competitive business advantages by maximizing the 
conversion value, lowering the costs, being the first to serve the markets, and increasing 
the customer care efficiencies (Bartlett & Ghoshal, 2013). These processes improved 
information‎flows‎and‎application‎to‎create‎the‎focus‎on‎the‎stakeholders’‎values‎
leveraging. Such values secure the sustainability of the organization and provide the 
strategic competitive advantage, which include human resources of‎managers’‎
competence as a fundamental factor for advancement (Bartlett & Ghoshal, 2013). 
Leaders of the strategic intent thinking values, visualize‎the‎stakeholders’‎values‎and‎
create the satisfaction with innovative strategic plans to improve, maintain, and gain the 
benefit in a long-term sustainable manner, particularly in the competitive markets 
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(Bianchi, Chiaroni, Chiesa, & Frattini, 2011; García-Morales, Matías-Reche, & Verdú-
Jover, 2011; Sharabati et al., 2010).  
The leaders of the organization deliver the long-term requirements that fulfill the 
vision, mission, and values to the lower managerial levels of the organization for 
implementation. The transfer for implementation is the short-term planning, 
implementations, and control, which are the management’s responsibility that manifests 
the understanding of the enterprise level strategy (Elving, Westhoff, Meeusen, & 
Schoonderbeek, 2012). The complexity of information and the level of the uncertainty 
determine the efficient strategy streamline performances, in which complex information 
and high uncertainty require effective enterprise-level strategy implementation 
(Montalban & Sakinç, 2013). The transformation of complexity and uncertainty is the 
managers’‎responsibility‎to‎create‎workable strategy levels for corporate, business, and 
functional levels that deal with more confirmed information and certain processes and 
procedures (Andries, Debackere, & van Looy, 2013).  
Enterprise-level strategy procedures are the expandable view of the organization 
that identifies the purpose of the foundation to generates public policies, and guides the 
corporate level to lead strategy implementation in multiple organizational activities with  
social and nonsocial preselected stakeholders values (Ditlev-Simonsen & Wenstøp, 
2013). Enterprise level strategy formulators combine the intent thinking and purpose of 
the formation to deliver the vision, mission, and value statements (Khanagha, Volberda, 
& Oshri, 2014). Strategy statements include joining and mixing initiatives to convey 
social, ethical, and legal codes of conduct that reflect the level of social responsibility 
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application (Hahn & Lülfs, 2013). Stakeholders enforce sublevels of the strategy 
implementation for actions and benefits of the organization long-term existence for 
continuous markets’‎competitive‎advantages‎(Teixeira‎&‎Werther,‎2013).‎The‎sublevel‎
strategies include the conversion of the enterprise-level strategy into procedural 
objectives, targets, actions, initiatives, and processes (Beamish & Lupton, 2016). These 
levels‎are‎conveyors‎for‎the‎employees’‎values‎in‎organizations‎that‎combine the 
intellectualities, creativity, and innovations for the advancement of the daily 
performances that reflect the stakeholders’ values (Xu, Zhang, & Ma, 2013). 
Leadership style is a critical factor in delivering objectives, creating awareness, 
motivating management, and controlling strategies implementations (Matzler, Strobl, & 
Bailom, 2016). Simoes and Esposito (2014) found improvement in resistance to change 
between management and leadership because of effective communication that leaders 
practiced during the change process. Effective communication between leaders and 
strategy implementers is critical to enhance competitive advantage and maintain a healthy 
business climate. Therefore, the introduction of change management that leaders aim to 
achieve during‎expansions‎and‎business‎development‎include‎managements’‎motivations‎
and awareness of the‎organizations’‎values recognition among strategy implementers 
(Fugate, 2012). 
Transformational leadership style is dealing with change management that leaders 
apply to leverage mutual benefits between leaders and followers through morality and 
motivations (Northouse, 2013). The introduction of change management includes 
transformational communication styles for information sharing among enterprise levels, 
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in which employees are the primary factors in introducing effective changes (Ahmad et 
al., 2014). Ahmad et al. found that through effective knowledge and sharing systems, 
companies can obtain better communication between management and employees to help 
achieve strategy tasks, which requires improvements in organizational culture, motivation 
method, organizational structure, and employee perception to increase the knowledge 
sharing positively. Therefore, transformational leadership is an effective leadership style 
that supports change management with mutual acceptance between employees and 
management. 
Management and employee acceptance during change management introductions 
is important for effective performance. Aalbers, Dolfsma, and Koppius (2013) studied the 
connectedness and interunit ties during change management processes, and they found a 
significant relationship between transformational leadership style and employees’ 
connectedness. The trustworthiness of the transformational leadership included 
information and knowledge flow for the appropriate benefits that stakeholders need to 
implement and support changes (Akhavan & Pezeshkan, 2014). On the other hand, 
Kottke, Pelletier, and Agars (2013) found employees with no confidence in leadership 
would‎not‎accept‎leadership’s‎ideas,‎which‎resulted in low scores on employees’‎
performance and employees tended to sabotage leadership strategy; in addition, conflict 
of‎interest‎was‎a‎cause‎for‎employees’‎lack of confidence in leadership. Therefore, 
acceptance of change is a generation of leadership style and follower perceptions that 
include mutual understanding and benefits. 
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Motivation is a transformational leadership‎tool‎to‎leverage‎followers’‎perceptions‎
that differentiated leaders and employees performances across organizations (Li, 
Sheldon, & Liu, 2015). Leaders need to practice the best intrinsic and extrinsic 
motivation to develop perceptions and leverage performances, which includ leaders’‎
understandings‎of‎the‎employees’‎motives‎(Benedetti,‎Diefendorff,‎Gabriel,‎&‎Chandler,‎
2015). Employees work because of personal benefits and interests, are employees with 
intrinsic motivation. Similarly, employees working for external affecting incentives or 
rewards are with extrinsic motivation behavior (Yoon, Sung, & Choi, 2015). Cerasoli, 
Nicklin, and Ford (2014) examined the relationship between intrinsic and extrinsic 
employees’‎motivations;‎and‎employees’‎performances, which indicated positive quality 
performance due to intrinsic motivation and positive quantity performance due to 
extrinsic motivation. Knowing the motivation drivers for employees is primitive for 
transformational leadership. 
Successful implementation of tasks is another motivating factor for employees 
that‎leaders‎need‎to‎evaluate‎and‎reward‎(Butt,‎Shafi,‎&‎Malik,‎2015).‎Employees’‎
motives and behavioral factors affecting performances are critical information for leaders 
for assigning tasks, introducing changes, or promoting initiatives (Lamm, Tosti-Kharas, 
& King, 2015). Expansion strategy is a challenging strategy for leaders introducing 
changes in organizations, in which employees will need adequate orientations, 
involvements, and task clarifications to evaluate results and maintain motivations (Dobni 
& Klassen, 2015). Therefore, transformational leadership style includes talent 
management and identification for alignment with core business advancements and 
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functional‎activities’‎performances‎during change management processes (Joyce & 
Slocum, 2012). 
Leaders in expansion strategy require the motivational talent for followers to 
implement strategy initiatives. Hirsch (2014) reported the transformational leadership 
effectiveness because of the cultural understandings, following performances, updating 
for achievements, and communicating effective practices that motivated workers. 
Rewards, recognition, and job satisfactions are additional characteristics for leaders to 
apply for change management, in which monetary reward is essential for different levels 
of organization (Malik, Butt, & Choi, 2015). Leadership encouragements and motivations 
include‎employees’‎engagements‎in‎sharing‎change‎management‎benefits‎and‎valuing‎
performances (Güntert, 2015). Therefore, transformational leadership is engaging 
employees for practicing changes and benefiting in a motivational environment that 
enhances development and competitive advantages. 
Expansion strategy in organizations is a requirement development process that 
includes innovation and creativity. Transformational leadership style is a practice for 
initiations and support of innovation and creativity, which is a critical change for 
competitive advantage (Schriber & Löwstedt, 2015). Burgess (2013) found critical 
communication style relationship between management and leader’s decision maker, 
which formed advancements due to sharing and engaging of strategy implementers in 
decision making processes for the organization. Transformational leaders apply 
engagement practices that the communication, trust, motivation, and awareness are 
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functional processes for developing mutual understandings for the sustainable 
organization in competitive business markets (Men, 2014). 
The competitive edge of organizations in a market environment is critical for 
developing the image and enhances performances, which leadership style determined by 
change‎introduction‎(Gotsis‎&‎Grimani,‎2015).‎Knowing‎the‎subordinates’‎capacities‎and‎
competencies are essential for leaders’ assignments for employees and managers that 
include‎evaluation‎for‎development‎requirement‎and‎expectations’‎measurements‎(Wallo,‎
Ellström, & Kock, 2013). In addition, leadership critical thinking is a further competence 
for leaders to evaluate, expect, and control‎performances‎that‎attainable‎target’s‎
capability of subordinates for the desired level of performances generates the competitive 
edge in the markets (Howard, Tang, & Jill Austin, 2015). Therefore, leadership business 
capacity and management performance are characteristics of organizations with a 
competitive edge in business environments. 
In addition to leadership business competency, leaders need acceptable behavioral 
characters‎that‎subordinates‎appreciate‎including‎ethical‎behavior‎affecting‎employees’‎
perceptions and performances (Xu, Loi, & Ngo, 2014). Demirtas and Akdogan (2015) 
found leaders to‎influence‎managements’‎and‎employees’‎behaviors‎because‎of‎the‎
leaders’‎characters‎that‎followers‎accepted‎from‎ethical‎believe‎in‎leadership.‎Wallo‎et‎al.‎
(2013) found leaders with more administrative involvements less effective in 
development orientation of the organization and found leaders with higher development 




effectiveness in development and learning. 
Transformational leadership style includes work enhancement, learning 
orientation, and encouragement for development at all organizational levels (Dubey, 
Gunasekaran, & Samar Ali, 2015). Dubey et al. examined leadership relationship 
management between managers internally and external entities, which is critical for 
organization’s‎advancement.‎Such‎relationships‎are the result of leadership learning 
orientation‎and‎performances’‎preferences‎that‎the‎leaders‎apply in companies (Dubey et 
al., 2015). Rewarding employees for completed achievements is the transactional 
leadership style that employees require, but satisfied employees appreciated more 
transformational leadership style for learning and development (Deichmann & Stam, 
2015). Deichmann and Stam found committed and motivated employees to realize 
acceptance of new ideas by leaders as an effective factor for transformational leadership 
style. Transactional and transformational leaderships are dealing with motivating 
followers‎using‎different‎approaches‎depending‎on‎followers’‎perceptions,‎values,‎
cultures, competencies, and needs (Eisenbeiß & Brodbeck, 2014). 
Leaders’ understandings of followers are significant in decision making‎ practices 
that leaders need to introduce changes and leverage performance (Kottke et al., 2013). 
Leaders must acquire the business‎as‎well‎as‎behavioral‎influences‎to‎develop‎followers’‎
knowledge that target the learning processes in the organizations to the advancement and 
competitiveness (Epitropaki, Sy, Martin, Tram-Quon, & Topakas, 2013). Competent 
leaders can forward influences in the organizational structure that the business 
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environment is changing because of external factors affecting organization performances 
(Parnell, Lester, Long, & Köseoglu, 2012). Leaders in such conditions are the finders of 
the‎required‎effective‎performances‎that‎maintain‎organizations’‎existence,‎particularly‎
during a crisis or changing regulations (Petrou, Demerouti, & Häfner, 2015).  
Pharmaceutical companies are examples of leadership resilience in the changing 
business and regulations environment because of new discoveries, financial crises, 
generic introductions, intellectual property rights restrictions, good manufacturing 
practices (GMPs) development, and increased the cost of innovation and development 
(Fisher, Cottingham, & Kalbaugh, 2015). Leadership style, orientation, knowledge, 
encouragement, and motivation are fundamentals for pharmaceutical companies to 
maintain competitiveness and existences, which contribute to innovative business models 
(Aslam, 2015). Such business models are introductory to mergers, acquisitions, licensing, 
technology transfer, franchise, innovation outsourcing, and products development 
(Michelino, Lamberti, Cammarano, & Caputo, 2015; Nishimura & Okada, 2014; 
Srivastava & Prakash, 2014; Wang & Li-Ying, 2014). Therefore, transformational 
leadership for pharmaceutical industries is an appropriate style to maintain a competitive 
business edge. 
Managers and Expansion Strategy  
Transferring organization vision to strategy actions is the leaders’ responsibility, 
while business strategy implementation is the responsibility of managers and leaders’‎
subordinates (Saini & Sengupta, 2016). Strategy implementation includes competent 
managers with effective performances that activate procedures and methods for leaders 
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desired visionary achievement (Joyce & Slocum, 2012). Therefore, effective strategy 
implementation is determinant of the management capacities and leadership style 
effectiveness. 
Management qualifications in business development are fundamental to achieve 
the expansion strategies for organizations (Davies, 2013). Davies discussed the inter 
firms deals and the third business party involvement in the international pharmaceutical 
transactions. Davies found the process dependent on the business development and 
licensing‎teams’‎negotiation,‎management,‎knowledge,‎and‎professional‎qualifications‎
that accounted for mutual benefits for the parties involved. Osabutey and Debrah (2012) 
found‎gaps‎in‎managements’‎qualifications‎for‎implementing‎professional‎expansion‎
processes between the expertise owners and the transferee party and recommended for 
inclusions of requirements for effective policies in organizations to develop the 
technology for the acquiring party. Therefore, certain business processes in the strategy 
implementation‎are‎susceptible‎to‎decline‎or‎disrupt‎because‎of‎managers’‎competencies. 
Leaders in strategy implementation must account for realistic activation of 
procedures and methods for execution by‎subordinates’‎evaluations‎for a capacity 
requirement or sufficiency (Beck & Wiersema, 2013; Sharda, 2012). Such evaluation 
includes indications for management evaluation of strategy implementation and levels of 
understandings‎of‎organizations’‎missions‎and‎values‎(Cantamessa‎&‎Montagna,‎2016).‎
The strategy implementers are the primary working factors for achieving targets and 
activate procedures.‎Managers’‎perceptions‎of expansion strategy are important for 




and Powell (2015) studied the managerial perception due to the effect of globalization on 
the strategic decision that managers applied for expansion strategy. Bowen et al. found a 
significant positive relationship‎between‎managers’‎perceptions and completed expansion 
strategy requirements. Therefore, leaders’ awareness about‎the‎manager’s‎strategy‎
implementation‎capacity‎is‎critical‎for‎effective‎expansion‎changes’‎requirements. 
Expansion strategy implementation is a process for including updates and 
introduction of developments to‎the‎organization’s‎system.‎The‎business‎models‎that‎the‎
organizations select for the expansion strategy vary depending on the strategy, internal 
productivity capacities, human resources, external business environment, cultural values, 
and regulatory enforcements (Bowen et al., 2015; Pak, Ra, & Lee, 2015; Patel, 2014; 
Srivastava & Prakash, 2014; Tantash, 2012). Managers during the strategy 
implementation stages must define the objectives of the strategy and prioritize the 
activities with an alignment that include multiple internal systems in the organization 
(Hirsch, 2014; Mastorakis & Siskos, 2016; Parnell et al., 2012). Integration and 
alignment are critical for new systems inclusion in the organizations, which leaders must 
visualize, follow, communicate, and evaluate (Simoes & Esposito, 2014). Leaders 
measure the effectiveness of the expansion strategy implementation by the model 
business workability and returns on investment (Dubey et al., 2015), which is the result 
of aligning capacities and integrating efforts. 
The leaders focus must include appointing capable managers for the expansion 
strategy in the right strategy task, in which managers align the effect of the 
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implementation of the strategy and organization objectives actively (Akhavan & 
Pezeshkan, 2014). Managers as strategy implementers need to understand the actions and 
initiatives that link organization values, cultures, and objectives for better performance in 
the strategy execution (Green, Albanese, Cafri, & Aarons, 2014). Friedrich von den 
Eichen, Freiling, and Matzler (2015) discussed the reasons for failing business models, 
which include management rejection due to (a) lack‎of‎managers’‎awareness,‎(b) lack of 
defining proper research about the business model, (c) logic application, and (d) cultural 
differences. Leaders’ knowledge‎about‎the‎managers’‎styles‎and‎thinking practices is a 
requirement for the application of appointing managers for strategy implementation. 
Managers’‎design‎thinking‎and‎practical‎applications‎are‎important‎foundation for 
expansion strategy implementation. Endenich, Hoffjan, Schlichting, and Trapp (2016) 
studied factors affecting harmonization between expanded business units for 
multinational companies with global presence. Endenich et al. (2016) found the 
challenges for harmonization dependent on qualities of national market employees, GMP 
regulations in the local market, and more important the management personalities in the 
local market that communicate with other markets. McMillan and Overall (2016) argued 
that‎managers’‎flexibility‎and‎awareness‎are‎critical‎for‎solving‎strategic‎problems‎during 
strategy implementation, which the changing market environment is creating. McMillan 
and‎Overall‎pointed‎that‎the‎senior‎managers’‎mindset,‎designing‎problem solving 
structures, and the performance system application are critical characteristics for the 
managers in strategy implementation. Therefore, appointing managers for strategy 
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implementation is a process that requires awareness of‎the‎managers’‎capacity‎and‎
competency. 
Transformational leadership is the leadership style that leaders apply to introduce 
changes through motivations. Managers and subordinates personalities, awareness, and 
culture alignment with organizational values is the leaders’ responsibility that introduces 
the appropriate change for strategy implementation (Donate & Sánchez de Pablo, 2015). 
Knowledge management practices that leaders apply in the organization motivate the 
acceptance to adapt changes for strategy implementation (Ahmad et al., 2014). Abraham, 
Morin, Renaud, Saulquin, and Soparnot (2013) found a significant relationship between 
knowledge‎experts’‎expectations‎from‎applying‎changes‎and‎effective‎motivations‎that‎
leaders applied. Therefore, the motivational application that transformational leaders use 
must address knowledge gaining about the changes and alignment requirement within the 
cultural organization approach. 
Transformational‎leaders’‎knowledge‎about‎the‎culture‎of‎managers‎and‎
subordinates is important for the motivational application. Huhtala, Feldt, Hyvönen, and 
Mauno (2012) studied the cultural effect on organizational goals implementation and 
found a significant relationship between ethical organizational culture and organizational 
goals‎oriented‎subordinates’‎desires,‎which‎supported‎leadership‎ethical and cultural 
application‎for‎better‎managers’‎goals implementation. Aalbers et al. (2013) found 
intrinsic and extrinsic motivation for managers to defer with the organizational cultural 
during important processes implementation for organization advancement. Understanding 
the culture, knowledge awareness, and motivational needs are the transformational 
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leadership applications for change introduction that provide the organization with 
competent managers for strategy implementation (Chan, Uy, Chernyshenko, Ho, & Sam, 
2015; Guay, 2016). The competent managers are capable of solving problems, 
communicating effectively, and tolerating cultural differences in the expansion strategy 
implementation. 
Internationalization is an expansion strategy objective that leaders deliver for 
implementation to managers and subordinates (Hadjikhani, Hadjikhani, & Thilenius, 
2014). Filiou and Golesorkhi (2014) discussed the importance of matching influential 
abilities of the partnering organization executives in the expansion process and described 
the levels of the advancements of the knowledge gain that contributed to successful 
implementation of the expansion activities. Filiou and Golesorkhi suggested that the 
global institutional framework influence the development of institutions at any level of 
development. Similarly, Bellamy, Ghosh, and Hora (2014) related the internal 
organizational changes requirement for development with the gaining from expansion 
strategy that the partnering, outsourcing, regulatory attainment or knowledge sharing 
imply during the process implementation. Therefore, awareness for adaptability is critical 
for leaderships and management during the implementation of expansion strategy. 
Pharmaceutical expansion strategy manager must adapt the regulatory 
requirement‎for‎products’‎marketing‎authorizations‎in‎the‎targeted countries (Civaner, 
2012). The adaptation includes changes introduction that must align with the regulatory 
requirement, which managers influence, adjust, implement, and control to satisfy the 
regulatory‎requirements‎(Wrona‎&‎Trapczyński,‎2012).‎Yadav (2013) studied the 
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processes that involved changing mechanisms to comply with standards for different 
regulatory requirements based on the targeted markets. Yadav found multiple managerial 
levels’‎involvements‎that‎need‎business,‎technical,‎and‎investment understanding to 
accelerate the expansion strategy effectively, which depend on communication and 
management‎styles‎in‎the‎organization.‎The‎manager’s‎technical‎capacity‎and‎managerial‎
intelligence are critical in advancing the expansion strategy, which leaders must support 
by leveraging the managerial understanding including technical competency (Wrona & 
Trapczyński,‎2012). 
Successful strategy implementation is a process that requires the utilization of 




making‎ management as primary competencies for managers to achieve the strategy 
objectives in organizations. Trong Tuan (2012) found a significant relationship between 
managers’‎transformational‎behavior‎and‎business‎targets‎effectiveness,‎which‎improve‎
business outcomes and advance organization image. Managers in advancing business 
effectiveness in organizations must combine technical and business qualification that 
leverage‎the‎stakeholder’s‎interest‎and‎attain‎business‎profitability‎(Miles,‎2012).‎In 
addition, the‎organization’s‎business‎performance‎is‎a‎stakeholder’s‎interest,‎which‎
managers maintain for effective business expansion and sustainability. 
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Stakeholders and Organization’s Performance 
Commercial application of the business expansion models that the advanced 
systems included formed intangible assets for the industry, which needs continuous 
maintenance and funding by the shareholders as primary stakeholders of the 
organizations (Esper et al., 2010; Guthrie, Ricceri, & Dumay, 2012). The strategy 
formulators’‎objectives‎include‎the‎prediction‎of‎the‎future‎positioning‎of‎the‎
organization's‎strategies‎by‎visualizing‎the‎internal‎organization’s‎system‎capacities‎and‎
the external market environment elements (Chatterjee, Randour, & Raskin, 2014). The 
practical implementation of the sustainable strategy includes defining the primary success 
factors for the analysis of the prevailing environmental factors (Lindgren, 2012). 
Lindgren‎included‎the‎capabilities‎of‎the‎organization‎that‎satisfied‎the‎customers’‎long 
term loyalty as a sustainable strategy for implementation, in which the value chain of the 
organization reflected sustainability. Focus approach is a successful way of identifying 
the primary success factors for pharmaceutical companies, in which the strategy 
formulators balance the internal resources and external demands to sustain the value 
objectives‎of‎the‎enterprise’s‎long term existences (Tatham & Spens, 2011; Teirlinck & 
Spithoven, 2013). Therefore, involving stakeholders in the expansion strategy is critical 
for‎organization’s‎sustainability. 
Leaders in organizations are responsible‎for‎stakeholders’‎adaptation‎to‎
organization’s‎competitive‎advantages.‎Verbeke‎and‎Tung‎(2013)‎proposed a framework 
for‎visualizing‎stakeholders’‎adaptability‎from‎the‎time of formation to the time of 
development strategy that required expansion for heterogeneity sources of incomes. 
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Verbeke‎and‎Tung’s‎framework‎included a transformational application that practices 
trust and effective communication with stakeholders for strategies formulations and 
benefits awareness. The key element of the stakeholder theory is to establish a beneficial 
relationship between business parties, which aims to generate an increase in wealth and 
benefits (Talbot & Boiral, 2015). The beneficial relationship includes supportive 
approach from stakeholders for the initiated changes in the organization that extended the 
effective performances (Hernantes, Rich, Laugé, Labaka, & Sarriegi, 2013). The 
extended performances are the results of the changing environment in the business, in 
which the expansion strategy implementation involves for the benefit of the stakeholders. 
Stakeholders are the directors of the organization activities and performances. 
Freeman's (2010) definition of stakeholders depended on organizations’‎interactions‎
within the business environments, which include parties from internal and external 
surroundings of the organization. Freeman extended the affected parties to include 
governments, competitors, suppliers, employees and regulatory parties. The 
organizations’‎activities‎involve‎changes,‎benefits,‎and‎developments,‎in‎which‎social‎
interactions consequences affected the organization's strategic performance (Miles, 
2012). Freeman focused on the identification of the benefiting and affected parties or 
individuals‎that‎contributed‎to‎effectiveness‎or‎declination‎of‎organizations’‎
performances.  
Stakeholders affect the organization performances because of the decision basis 
that the stakeholders make for or against the organization. Decision making‎ theory 




process‎is‎affecting‎the‎organizations’‎performances‎by‎supporting, advancing, or 
declining the leaders’ decisions for changes or modifications that the current market 
environment involves for competitive advantage (Hernantes et al., 2013). Paul (2014) 
described the relationship between stakeholders as a critical influence on the decision 
making‎ process, which effective communication and transparency with trust mitigate the 
effectiveness of the organization in the competitive business environment. The 
transformational effectiveness of the organization includes effective communication and 
transparency that leaders, managers, employees, customers, and regulatory authorities 
practice during the change management processes (Cui, Li, Meyer, & Li, 2015). 
Therefore,‎transformational‎leaderships’‎actions‎and‎stakeholders’‎understandings, with 
alignment, are critical for expanding business and gain competitive advantage.  
Stakeholders’‎decisions may affect the resources allocation that organizational 
leaders require for effective strategy implementation. Scheibehenne, Rieskamp, and 
Wagenmakers (2013) provided theoretical framework using Bayesian inference technique 
that uses beliefs and behaviors of individuals to determine the actions that individuals 
make. Scheibehenne et al. (2013) indicated for the application of the model for the 
expansion strategy, which could apply to the stakeholders as the primary influencers for 
the organization resources facilitation to understand the forces driving the decision 
making‎ processes. Such forces might not include monetary benefits only but extend to 
social, environmental, and pride values that the supply chain management, investment, 
and purchasing behaviors of stakeholders control the organization activities and 
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expansion decisions for sustainable performances (Wolf, 2014). Therefore, knowing the 
stakeholders‎influencing‎needs‎is‎critical‎for‎organizations’‎leaders to implement the 
expansion strategy effectively. 
Wolf‎(2014)‎examined‎the‎external‎stakeholders’‎effects‎on the sustainable supply 
chain‎management’s‎practices‎and‎found a significant impact on ethical organizational 
performance‎on‎organizations’‎strategies‎on‎markets’‎expansions.‎The‎external‎factors‎
include forces that impact the organizational performances depending on the 
understandings of the stakeholder and the affected benefits of the stakeholders (Balmer, 
2013). Effective communication includes the right information delivery, at the right time, 
and for the right people, in which employees, shareholders, investors, customers, 
suppliers, and regulatory authorities need transparent information about the 
organizations’‎activities‎and‎performances‎(Martin, Miranda Lakshmi, & Prasanna 
Venkatesan, 2014). Martin et al. (2014) found multiple levels of communication between 
the organization and stakeholders that require effective analysis, which the decision 
makers used for the organization competitive advantage. Therefore, transformational 
stakeholder’s‎effectiveness‎depends‎on‎the‎accurate‎data‎analysis‎and‎information 
communication that the organization strategy requires for the continuous support of 
stakeholders to the expansion strategy implementation. 
Expansion strategy implementers are the managers in the organization. These 
managers convert the strategy initiative into monetary values that the stakeholders 
evaluate as returns on investment (ROI), which is the primary key performance indicator 
(KPI) for the leaders and managers in the organization (Vallejo & Wehn, 2016). The 
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expansion strategy implementation includes ethical performances for ROI, in which the 
unethical conduct cause adversely affected stakeholders (Hahn & Lülfs, 2013). Analytical 
application‎of‎the‎stakeholders’‎values‎is‎critical‎for‎the‎expansion‎strategy‎to‎indicate‎for‎
the benefiting parties with supporting efforts for investments and controlling or avoiding 
negatively affected parties within the organization activities (Öberseder, Schlegelmilch, 
& Murphy, 2013). Therefore, managers in expansion strategy implementation must 
acquire the stakeholders’‎values‎for‎effective‎strategy‎implementation. 
Expansion strategy analysis includes identification of stakeholders for effective 
strategy‎implementation.‎Baker‎(2013)‎posited‎that‎social‎organization’s‎effect‎on ROI 
generation as critical transformational value for communication with customers for 
effective corporate social responsibility (CSR) practices, which customers needed 
because of the evolved technological advancement. Prasad and Holzinger (2013) applied 
extensive literature analysis research on marketing CSR practices and recommended 
ethical‎distinction‎between‎monetary‎and‎social‎values‎for‎different‎stakeholders’‎benefits‎
including unknown stakeholders, which globalization included because of the 
technological advancement, wide availability, and easiness of accessibility. Expansion 
strategy implementation includes CSR practices for effective ROI that include active and 
potential‎stakeholders‎for‎managers’‎considerations. 
Active and Potential Stakeholders 
The dynamic business environment is a generation process of new involvements 
of multiple parties. The parties’ effects on the organization performances include the 
positive and negative influence of the organization activities depending on the benefits or 
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risk‎that‎the‎organization’s‎performances exert on the stakeholders (Arena & Arnaboldi, 
2014). Customers, shareholders, employees, regulatory authorities, and society members 
are the affected‎parties‎of‎the‎organizations’‎performances,‎which‎similar‎unanticipated‎
stakeholders from a potential for the organization if communicated effectively for 
expansions activities interests (Mitchell, Van Buren, Greenwood, & Freeman, 2015). 
Technological advancement and accessibility are one of the millennium globalization 
tools for searching and defining interests that potential stakeholders apply to gain 
knowledge‎about‎organizations’‎performances‎(Tsai‎&‎Bagozzi,‎2014).‎Mitchell‎et‎al.‎
(2015) found accounting stakeholders in the expansion strategy as critical communication 
factor for the implementation that includes the expectations of the affected parties due to 
the expansion activities. Therefore, defining stakeholders for the expansion strategy is 
primitive for effective strategy implementation. 
Pharmaceutical‎industries’‎applications‎of‎expansion‎strategy include multiple 
stakeholders‎accounting‎for‎effective‎implementation.‎Wrona‎and‎Trapczyński‎(2012)‎
explored the factors affecting marketing expansion strategy for pharmaceutical 
companies‎and‎found‎the‎interdependencies‎between‎the‎stakeholders’‎to‎be critical for 
strategy‎implementations.‎Wrona‎and‎Trapczyński‎posited‎that‎knowledge‎about‎
customers, marketing employees, regulatory authorities, and society members in the 
targeted markets was a critical construct for developing appropriate entry and expansion 
implementation,‎which‎depended‎on‎the‎managers’‎communication,‎confidence,‎and‎
previous‎experiences.‎Alkhaled‎et‎al.‎(2014)‎examined‎studies‎for‎influencing‎physicians’‎
prescriptions by medical representatives, which included knowledge sharing among 
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parties and preference selection. Alkhaled et al. recommended collaboration between 
regulatory authority, industrial entities, patients, physicians, and communities to benefit 
from the marketing processes and mitigate adverse effects that the influencing process 
included. Therefore, accounting for stakeholders is critical for expansion strategy that 
leaders and managers in pharmaceutical companies must practice for effective expansion 
strategy implementation. 
The‎advanced‎pharmaceuticals‎system’s‎commercialization enforced the 
competitive advantages by identifying business expansion models for collaborating, 
supplying, and servicing industries in different regions that integrate to accomplish tasks 
(Mehralian, A. Nazari, Akhavan, & Reza Rasekh, 2014). Mahsud, Yukl, and Prussia 
(2011) discussed the influence of the effective linkage between the human capitals that 
industries required for innovation, strategy implementation, and competitive advantages 
creation of the organizations including other available capital resources. Mahsud et al. 
(2011) concluded that the human capital advantages were a valuable resource for the 
organizations, which stakeholders viewed as leveraged value for the competitive 
advantages to account for new opportunities. Therefore, accounting for internal human 
capital capacity is significant for expansion strategy that stakeholders value as 
advantageous for the organization performances. 
Qualification and experience of human capital in expanding organization is an 
important factor for stakeholders’ trust‎and‎appreciation.‎The‎expansion‎strategy‎systems’‎
integrations and synchronizations must reflect the cybernetic advancements of the use of 
the expansion strategies (Singh & Jayanti, 2013). The feedback processes and the 
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communication integration support the synergy requirements in the organization to 
harmonize the different efforts toward the objectives of leveraging the stakeholder's 
values. Hinterhuber and Liozu (2012) suggested that marketers must educate customers 
as potential stakeholders about the value added cost and motivate the willingness of the 
customers to pay for that value. Hinterhuber and Liozu encouraged leaders in 
organizations to keep evaluating strategies and the negotiation techniques for better 
understanding of the customer value because customers are important stakeholders. 
The strategic expanding of organizational relationships and interdependencies of 
the‎business‎environment‎are‎enforcing‎organizations’‎responsibilities‎in‎global‎markets,‎
in which human capital intelligence is an advancing factor for effective strategy 
implementation (Sohrabi, Asari, & Hozoori, 2014). The extended relationships for the 
expansion strategy are factors for creating the stakeholders of the organizations within the 
internal and the external interdependencies (Mason & Simmons, 2014). The satisfaction 
of the stakeholders of the organizations becomes an important factor for the sustainability 
and competitiveness of the markets (Mehralian et al., 2014). Finding effective 
relationship between the internal and external stakeholders is a determinant for expansion 
strategy application and longevity effectiveness (Napolitano, Marino, & Ojala, 2015), in 
which increasing the number of potential benefiting parties supports the expansion 
strategy effectively (Ocasio & Radoynovska, 2016). Therefore, leaders and managers in 
pharmaceutical industries must satisfy the demands of existing and expected stakeholders 
for the expansion strategy. 
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Organizational Management Relations in Pharmaceutical Industries 
Pharmaceutical industries constitute of divers, integrate objective, and interactive 
systems in complex changing business and scientific climate (Nagurney, Li, & Nagurney, 
2013). The scientific nature of the pharmaceutical industries and knowledge base 
formation including the high impact on the lives of the intended consumers guided the 
international‎healthcare‎organizations‎to‎regulate‎the‎pharmaceutical‎companies’‎
activities through enforcing GMP (Frau, Font Pous, Luppino, & Conforti, 2010). These 
regulations‎are‎for‎controlling‎and‎inspecting‎the‎systems’‎operations‎as‎an‎integral‎part‎
of the market authorization requirements (Yadav, 2013).  
The complexity of the pharmaceutical industries included the involvements of the 
systems that contributed to the predictions of the expected expansions of marketing 
competitiveness (Malerba & Orsenigo, 2015). These factors include the research and 
development (R&D), engineering, quality systems, production, marketing, and human 
resources (HR) integration for processes implementation (Gilsing, Nooteboom, & 
Gilsing, 2004), which must comply with GMP regulations (Nguyen, Seoane-Vazquez, 
Rodriguez-Monguio, & Montagne, 2013). Mehralian et al. (2013) studied the 
contribution of the intangible and intellectual capitals of the pharmaceutical systems to 
the advancement of strategies and discussed the importance of the collaborations’‎
requirements as a business expansion model of the internal systems. Mehralian et al. 
included employees, managements, and CEOs qualifications and awareness as critical 




enforcement requirements, and managing the future implications of operational activities 
are critical factors for organizations to implement and to attain the sustainable 
organizations’‎goals‎(Enkel‎&‎Heil,‎2014;‎Oerlemans,‎Knoben,‎&‎Pretorius,‎2013).‎These‎
key factors are measures of advancements, control, and effectiveness of the business 
expansion models that the leaders select to apply for the expansion strategy. 
Adding value by applying expansion strategy is the aim for business growth and 
advancement.‎Stakeholders’‎views‎and‎approvals‎for‎the‎expansion‎strategy‎added‎values‎
are critical for benefits acquirements and wealth generation, which determine the 
effectiveness‎of‎corporate‎systems’‎integrations‎(Hallbäck‎&‎Gabrielsson,‎2013).‎The‎
selection between the different business expansion models is leaders’‎responsibilities,‎
which include the evaluation of internal deliver capacity and market absorption capacity 
(Yang, Chen, & Wang, 2015). Rahman and Lambkin (2015) examined 45 business 
mergers and acquisitions, as an expansion model, to investigate the relationship between 
expansions intended model and added value resulted from the process. Rahman and 
Lambkin found a significant relationship between cost reduction and increased ROI, but 
the process included a reduction in marketing efficiency, which the authors indicated as 
failure to increase sales that affected other business processes. Adding value processes 
through expansion strategy is critical for business and requires a collaborative 
understanding between managers and leaders to mitigate affected processes. 
Pharmaceutical‎business‎management‎for‎expansion‎strategy’s‎implementation‎is‎
a collaborative process‎between‎internal‎company’s‎component‎and‎external‎market’s‎
requirements. Campbell et al. (2015) suggested a comprehensive quality indicator for 
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marketing authorization that includes business efficiencies for cost effective products, 
factors for introducing products to market, patient and professional involvement, and 
technology application. Campbell et al. aimed to validate the quality, transparency, and 
regulation for effective application. The components included in Campbell et al. model is 
results for internal collaboration among management parties in the company and the 
intended expansion strategy for the regulation environment in the regulating country. 
Nagurney‎et‎al.‎(2013)‎examined‎the‎outsourcing‎effect‎on‎pharmaceutical’s‎quality‎and‎
cost, which included the collaboration among internal management of business and 
quality department for the decision making‎ process of the expansion strategy. Therefore, 
pharmaceutical manufacturing systems and business expansion strategy must integrate to 
add value and improve sales achievements. 
Pharmaceutical’s‎GMP‎regulation‎compliance‎and‎business‎achievement‎are‎
managers’‎responsibilities. Pagani and Otto (2013) studied the complex system of 
marketing medicines to propose a quantitative follow-up framework that can help 
systems’‎managers‎to‎achieve‎targets.‎Decision making‎ and adjustability to variations 
depended on‎the‎managers’‎competency and understanding of the organizational system 
involved in pharmaceutical product and market development (Pagani & Otto, 2013). 
Collective decision making‎ process between competent managers facing marketing 
turbulence achieved practical policy adaptation to leverage competitive business 
advantages (Pagani & Otto, 2013). Sharda (2012) explained the detailed processes that 
involve‎mapping‎managers’‎competencies‎and‎talent‎management‎in‎a‎pharmaceutical‎
company. The processes included the combination of knowledge, experience, and 
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competence for business and technical qualification that the company leaders develop in 
managers to achieve strategy targets (Sharda, 2012). Therefore, pharmaceutical 
organizational systems and management responsibility must align‎with‎the‎managers’‎
competencies to develop competitive advantages for expansion strategy implementation. 
Information flow between organizational components is critical in the corporate 
pharmaceutical system. Pharmaceutical industries are scientific knowledge base 
industries‎that‎include‎scientific‎discoveries,‎market‎preferences,‎regions’‎demands,‎and‎
epidemics fighting within the business construct to achieve social and economic targets 
(Belderbos, Gilsing, & Suzuki, 2015). Tierney, Hermina, and Walsh (2013) selected the 
pharmaceutical landscape technology for their study as a technique that accommodates 
dynamic changes within the technology set of radical changes in the industry. Tierney et 
al. (2013) studied the road mapping efforts for the innovations that are increasingly 
failing to meet the primary goals of technologies into the strategic process of firms, 
regions, or industries. Tierney et al. concluded that techniques include a promise to 
provide superior value to the strategic process of firms, industries, and regions seeking to 
profit‎from‎innovations‎born‎of‎more‎than‎one‎technology.‎Therefore,‎organization’s‎
information flow system is critical in linking and delivering the knowledge between the 
different components of collaboration and combination of talents, experience, and 
effective implementation. 
Combining information from different organization components is the leadership 
and management responsibility that include information’s‎system design and organization 
to achieve the competitive advantages (Qader et al., 2013). Qader et al. examined 
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relationships between knowledge management and competitive advantages in 
pharmaceutical firms. Qader et al. found managers practicing a combination of 
knowledge management achieved higher levels of competitive advantage, which included 
acquisition, dissemination, and responsiveness to knowledge. These practices must 
include market orientation that engages customer and competitor. Wilson, Perepelkin, 
Zhang, and Vachon (2014) investigated relationships between market orientation, 
alliance orientation, and business performance in a biotechnology industry. Wilson et al. 
(2014) found a significant relationship between market orientation and business 
performance, which supported the existence of a mediation relationship. Wilson et al. 
concluded that behavioral orientations toward customers, competitors, and business units 
were‎important‎to‎increase‎business‎performance‎including‎managers’‎understandings‎of‎
the sequential relationship between the market-oriented behavioral commitments, alliance 
oriented activities, and business performance outcomes. Therefore, managers must pay 
particular attention to alliance scanning, coordinating, and learning because these 
activities improve business performance.  
Practitioners’‎and‎scholars’‎studies‎in‎pharmaceutical‎industries‎included‎
innovation‎competencies‎that‎managers’‎apply‎to‎leverage‎edge‎for‎competitive‎
advantages (Epitropaki et al., 2013; Hu, McNamara, & McLoughlin, 2014; Kim, 2014; 
Montalban & Sakinç, 2013; Pollock, 2014). The innovation practices in pharmaceutical 
industries included introductions of business models for expansion strategy to enhance 
business effectiveness (Erden, Klang, Sydler, & von Krogh, 2014). Montalban and 
Sakinç (2013) examined the effects of financialization and competition on productive 
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models in pharmaceutical companies. Montalban and Sakinç found pharmaceutical 
companies’‎adaptations‎of‎blockbuster‎model‎maximized‎shareholder‎value,‎which‎
included financialization, technical change, product market regulations, and market 
competition. Montalban and Sakinç concluded that institutional investors are accelerators 
for‎transformational‎business‎models‎that‎must‎align‎with‎managers’‎controls‎and‎
practices during expansion strategy implementation as an effective business model for 
competitive advantage. Therefore, selecting business expansion model for pharmaceutical 
industries‎must‎align‎with‎managers’‎organizational‎competencies,‎external‎markets’‎
competitions,‎and‎stakeholders’‎demands.  
Strategic Business Expansion Models in Pharmaceutical Industries 
Scholars and practitioners provided different studies in business expansion 
models from‎the‎time‎of‎the‎introduction‎of‎the‎“strategic‎intent”‎that‎Hamel‎and‎Prahalad‎
posited in 1989. Business expansion models are part of the corporation strategy for 
growth and profit generation that leaders‎formulate‎by‎depending‎on‎the‎corporation’s‎
components‎and‎managers’‎motives,‎competences,‎understandings,‎and‎qualifications‎to‎
achieve the strategy targets (Martin, 2014). Enterprise managerial levels are important 
formulators of the appropriate expansion strategy and method of implementation, which 
decision making‎ process involved (Chen, Liu, Ni, & Wu, 2015). Chen et al. (2015) 
examined the relationship between strategic intent and external business factors affecting 
expansion strategy. Chen et al. found a significant relationship between the variables and 
posited that expansion strategy and decision making‎ processes must align with intentional 
and organizational capacities to achieve successful expansion strategy implementation. 
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Therefore, expansion strategy includes multiple factors of the decision making‎ process 
that leaders and managers must acquire to select the appropriate expansion strategy 
within or outside the business constructs of the organization. 
Business expansion strategies are of different types and nature in the literature. 
Scholars and practitioners collected evidences of expansion strategy that include (a) 
products and markets concentration, (b) integration of existing processes or products to 
add value, (c) diversification of products or services to gain opportunities, (d) cooperation 
with competitors or new entities, and (e) internationalization that include new regional 
markets in global view (Hoppner & Griffith, 2015). The following subsections include a 
description of these expansion strategies types with emphasis on pharmaceutical 
industries. 
Concentration. Concentration‎is‎the‎process‎of‎increasing‎products’‎availability‎
in existing markets for current and potential customers (Mehta, Hasan Farooqui, & 
Selvaraj,‎2016).‎Pharmaceutical‎marketing‎managers’‎are‎the‎implementers‎of the 
concentration‎strategy‎by‎coordinating‎operations‎productivity‎and‎markets’‎demands,‎in‎
which concentration strategy would increase productivity with alignment between the 
factory‎and‎markets‎(Salih‎&‎Doll,‎2013).‎The‎requirements’‎for‎managers’‎collaboration‎
and effective communication is critical in implementing the concentration strategy. 
Markets’‎demands,‎internal manufacturing capacities, and supply chain processes are 
critical‎factors‎for‎the‎concentration‎strategy,‎in‎which‎managers’‎application‎of‎agile‎and‎
effective‎supply‎of‎products‎must‎match‎the‎products’‎demands‎in‎the‎markets‎(Töytäri‎&‎
Rajala, 2015).  
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The advantages of concentration strategy include strengthening business, cost 
reduction, customer loyalty, and effective assets utilization (Mintz & Currim, 2013). In 
pharmaceutical industries, concentration process is beneficial because products exist in 
the market, known to customers, and no further registration costs needed. The expansion 
strategy with concentration includes identification of potential customers, leveraging 
competition, increasing marketing efforts, and aligning productivity to satisfy demands 
(Mintz & Currim, 2013). These factors are applicable for expansion in markets with an 
effective‎branding‎strategy‎that‎marketing‎managers‎apply‎to‎influence‎products’‎
competitive advantages by developing trust and transparency in marketing mix 
formulation (Helm & Gritsch, 2014). Therefore, the application of concentration strategy, 
as an expansion strategy, is beneficial for organizations with known brands and capable 
of responding to marketing efforts. 
Integration. Integration is the strategy that includes combining application of 
existing processes to serve existing customers through cross-functional teams focusing on 
serving customers (Turkulainen & Ketokive, 2012). The integration strategy processes 
include a high level of communication and information flow that leaders observe and 
evaluate to convey appropriate performances to the expansion strategy. Expansion by 
integration involves multiple organizational functions starting with the supply chain 
management to business-to-business formulation (Kozlenkova, Hult, Lund, Mena, & 
Kekec, 2015). Gligor, Esmark, and Holcomb (2015) found a significant relationship 
between integration strategy and supply chain management for agile manufacturing that 
managers required for cost reduction strategy during uncertain environmental 
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turbulences. Similarly, Zhang, S. Pawar, Shah, and Mehta (2013) investigated the 
relationship between evaluating outsourcers and managing outsourcing relationships in 
the pharmaceutical industry based on the theory of dynamic capability. Zhang et al. 
(2013) found pharmaceutical companies outsource to include integrated relationships 
with high dynamic capabilities, which manufacturing industries must efficiently and 
effectively evaluate and manage to deal with the challenges and risks associated with 
strategic expansions. Integration for expansion strategy includes benefits for 
organizations and stakeholders. 
Expansion strategy by integration is beneficial for controlling distribution 
channels and serving targeted customers. Patel (2014) studied the retail channel 
expansions through the integration of marketing and technical assets in relation to 
customers’‎perception‎and‎acceptance.‎Patel‎found‎failures‎on‎levels‎of‎integration‎
created an imbalance on meeting customer preferences and adapting new market 
acceptance. The integration between downstream and upstream supplies in 
pharmaceutical industries is critical because of the regulated processes involved that 
requires effective communication, trustworthiness, scientific presentations, and fast 
respond (Valverde, 2013). Therefore, effective expansion strategy by integration must 
include appropriate communication, transparent partnerships, and qualified strategy 
implementers. 
Diversification. Diversification in expansion strategy is the application of new 
products, markets, or methods of the business that change or modify the business 
intention purpose (Benito-Osorio, Guerras-Martín, & Zuñiga-Vicente, 2012). Scholars 
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and practitioners studied the diversification process that leaders introduced in different 
industries and services to evaluate the value added by the process (Benito-Osorio et al., 
2012).‎Boz,‎Yiğit,‎and‎Anil (2013) studied the difference between types of diversification 
and performance values. Boz et al. (2013) found performance indicators increased in 
single and dominant businesses with diversification. The authors concluded that 
increased performance level resulted as diversification focused on the internal resources 
more than environmental opportunities. The applicants of diversification must account 
for the manufacturing development and capacities to leverage the values for the 
expansion strategy that would satisfy‎the‎stakeholders’‎intentions. 
Diversification processes for expansion strategy are of different types in literature. 
The introduction of a new‎product‎line‎within‎the‎organizations’‎activities‎is‎a‎directive‎
for diversification concentration, which includes the acquirement of new technologies, 
research and development, or investments (Sisodya & Johnson, 2014). For example, 
pharmaceutical industries are developing new products for treatments and new 
formulations for convenient uses, which the end users would value as a new change for 
better convenience application (Barei, 2013). Similarly, mergers and acquisitions (M&A) 
of different core businesses between organizations are diversifications that leaders aim to 
gain markets share, competitive advantages, or cost reduction by developing new 
business line or transform the existing lines (Rahman & Lambkin, 2015). Diversification 
types‎or‎processes’‎selections‎must‎align‎with‎the‎leadership‎transformational‎intentions‎
and‎managers’‎acceptance‎to‎implement the expansion strategy. 
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Srivastava and Prakash (2014) studied the determinant factors for the evidence of 
value creation through international M&A activity. Srivastava and Prakash indicated that 
the diversification through M&A strategy was a solution for problems of tacit knowledge 
transferring, which lead to competitive advantages in the pharmaceutical industry and the 
rise of R&D activity. The development of these factors was the result of expansion 
strategy‎through‎diversification‎that‎served‎products’ developments‎and‎new‎products’‎
entries to the markets. Tripathy and Prajapati (2014) accounted for the benefits of 
diversification through M&A, which includes the development of competitive 
advantages; improve the value chain, new market entries, products’‎availabilities,‎and‎
local‎market‎services’‎developments.‎Therefore,‎the‎expansion‎strategy‎is‎an‎advantage‎
for the company because of developing the know-how of the organization to compete 
internationally and better serve current customers. 
Cooperation with competitors. Scholars and practitioners studied the expansion 
strategies between competitors that lead for cooperation to gain added value and prevent 
new entrants into the market (Liu, Kauffman, & Ma, 2015). The cooperation processes 
between competitors included similarities with M&A but with defined formats that 
maintained the structures of cooperating organizations (Hallbäck & Gabrielsson, 2013). 
Joint ventures formation between competitors is an example of expansion strategy 
through cooperation. Park, Vertinsky, and Becerra (2015) studied the effect of tacit and 
explicit knowledge transfer from foreign parents on the performance of young and mature 
international joint ventures (IJVs). Park et al. (2015) conducted a study to define the 
relationship between IJV, knowledge transfer, and performance. The authors found that 
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IJV age influenced the transfer of tacit knowledge positively while the transfer of explicit 
knowledge declined. The authors found knowledge transferred to influence the 
performance of both young and mature IJVs and the transfer of explicit knowledge 
significantly affected mature IJVs performance. Therefore, the cooperation between 
competitors is an expansion strategy that leaders apply to change and develop business in 
competitive advantage. 
Licensing-in, licensing-out, franchising, technology transfer, and know-how sales 
are forms of expansion strategy through cooperation between competitors, which include 
diversification and internationalization (Bosch-Sijtsema & Henriksson, 2014; Dant & 
Grünhagen, 2014; Yildiz, 2013). Oh and Contractor (2014) posited‎that‎companies’‎
leaders with practiced local cooperation between competitors implemented effective 
cooperation with regional and international partners. Strategy implementation is a 
dependent process on the understanding of the decision making‎ managers in the 
cooperation progression and leaders updating, which is a critical setup for the strategy 
choices that leaders must acquire and develop (Hennart & Slangen, 2015; Shaver, 2013). 
Cost‎and‎benefit‎including‎managers’‎cognitive‎approaches‎to‎implementing expansion 
strategy or the decision making‎ progression are important factors for the choices that 
leaders need for selecting the appropriate expansion strategy for cooperation with 
competitors (Hansen & Grunow, 2015; Lengnick-Hall, Lengnick-Hall, & Rigsbee, 2013). 
Cooperation between competitors includes strategic alliance that leaders design to 
increase benefits and gain competitive advantages within the same organization construct 




advantages through alliances. Boden and Yassia Paul posited that alliance management is 
a‎relational‎activity‎more‎than‎technical‎function.‎The‎authors‎defined‎managers’‎skills‎of‎
awareness, communication, and structural position affecting activity in the firm as critical 
factors for alliance strategy implementation. Bérard and Perez (2014) studied the alliance 
dynamics between competing pharmaceutical companies through the real options model. 
Bérard‎and‎Perez’s‎study‎included‎the‎R&D‎alliances‎that‎the‎companies‎were‎applying‎
to decrease uncertainty, increasing flexibility, gaining experiences, and knowledge 
dynamics. Bérard and Perez developed a complex qualitative model for the system 
dynamics and real options approach to understand the complexity and the dynamics 
surrounding the opportunities and threats of strategic alliances between competitors 
around an R&D project in pharmaceutical industries. The authors described the critical 
role of the human factor behavior and understanding for the dynamics of the alliances 
implementation. Bérard and Perez found that managers must align with the alliances 
value-added and appreciate the value of the real option evolved from the alliances to 
leverage the corporate benefits. Therefore, leaders must define the role of managers in 
expansion strategy and the competency requirement to implement the process. 
Internationalization. Internationalization is the expansion strategy that the 
organizations’‎leaders‎design‎for‎expanding‎activities‎outside‎the‎national‎market’s‎
border to increase benefits and add value for stakeholders (Knight & Liesch, 2015). 
Compliance‎with‎international‎markets’‎requirements‎is‎critical‎to‎achieve the expansion 
strategy, which includes competitive pricing method, quality proves, and on-time 
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delivery (Homburg, Vollmayr, & Hahn, 2014; Yadav, 2013). The internal capability of 
the organization is a determinant of the internationalization implementation and the 
choices for procedures to follow. The choices for internationalization include (a) deliver 
products or services to new markets due to unavailability, (b) customizing products and 
services, (c) selective global customer or product, or (c) a combination of all procedures 
to gain the competitive advantage of internationalization (Hadjikhani et al., 2014). 
Expansion strategies through internationalization are in various forms of the 
literature. The commercial applications and transferring gained knowledge, know-how, 
and R&D results are forms of intangible assets internationalization for pharmaceutical 
industries (Esper et al., 2010; Guthrie et al., 2012). The advanced pharmaceutical 
intangible‎systems’‎commercializations are forms of competitive advantages for 
expansion of inter-technology transfer for developing industries in different regions 
(Mehralian et al., 2014).  Yadav (2013) studied the challenges faced for 
internationalization of pharmaceuticals regarding managing regulatory requirements in 
different international markets. Yadav performed the study to account for the 
requirements of regulation in different markets. The author found the knowledge in plant 
approval requirement in regulating country and product registration procedures are 




important for effective implementation. Dixit and Yadav (2015) explored the 
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motivations, obstacles facings, and benefits perceptions of managers practicing 
internationalization in early and advanced stages. Dixit and Yadav performed the study to 
understand and analyze the Indian pharmaceutical firms that have knowledge on the early 
phase of internationalization and to compare with early entrants. The authors found that 
motives for internationalization were different including before and after 
internationalization. The authors concluded that empowerment is important for managers 
to fill the competency gaps in early internationalization. In addition, expansions in 
stringently regulated markets were beneficial for organizations to prove trustworthiness 
for local market reputations and facilitation of further expansions with 
internationalization strategy. 
Transition  
In Section 1, I included the foundation for the study. Section 1, I described the 
background of the problem; purpose and nature of the study, the research question, the 
conceptual framework for the study, key terms definitions. I included a description of the 
assumptions, limitations, and delimitations, and I mentioned the significance of the study. 
In addition, Section 1 included a review of the related literature for the study in relation 
to the conceptual framework and research topic. Section 2 includes the research project 
design for the expansion strategy implementation in Jordanian pharmaceutical 
companies; data collection technique and analysis; and reliability and validity of the 
study. Section 3 includes the presentation of findings, application to professional practice, 
the implication for social change, recommendation for action, and future study. I ended 
Section 3 with the summary and conclusion. 
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Section 2: The Project 
In Section 1, I explained the problem statement. Implementing expansion 
strategies in pharmaceutical companies includes leadership and stakeholder implications, 
which I discussed in the literature review. Exploring the implementation of the expansion 
strategies used in some Jordanian pharmaceutical companies may provide knowledge 
about the factors and requirements for successful developments of expansion strategies. 
The development requirement may provide organizations with the competitive 
advantages of expanding activities for better performance. Aligning the internal 
developments of the production capacities and management performances must include 
the‎external‎markets’‎absorptive‎capacity‎in‎the‎target‎markets,‎which‎I explored in this 
study. 
I applied the project parameters for a qualitative method to suit the purpose of this 
study. In Section 2, I address the study’s project, which includes subsections. The 
subsections for this study are (a) the purpose statement, (b) role of the researchers, (c) 
participants, (d) research method, (e) research design, and (f) population and sampling. 
The subsections include the reliability and validity of this study and the data collection 
instruments and techniques. Section 2 also includes the ethical research subsection for the 
ethical presentation of the study.  
Purpose Statement 
The purpose of this qualitative descriptive multiple case study was to explore 
effective application of expansion strategy among Jordanian pharmaceutical managers ‎to 
satisfy the demand in MENA markets. I interviewed four CEOs and eight managers from 
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generic pharmaceutical companies in Jordan who practiced and succeeded in applying 
expansion strategies in the MENA region. I selected participants purposely from 
Jordanian pharmaceutical managers who were experienced in the professional application 
of expansion strategies in MENA markets. In addition, I applied member checking and 
document review to achieve the triangulation for the validity and reliability of the study 
(Yin, 2014). My findings may improve knowledge and efficacy of strategies and 
practices for expanding business in the MENA region to satisfy potential market 
demands. The remote MENA communities lack adequate pharmaceutical supplies and 
suffer from different diseases that the generic essential medicines supplies could help 
resolve in communities (UN Millennium ‎Development Goals, 2014). These communities 
are potential stakeholders who could benefit by increasing generic medical supplies, 
thereby meeting both physician and patient needs for increasing availability and 
decreasing costs of generic pharmaceuticals to fight diseases. 
Role of the Researcher 
Qualitative researchers are the primary instruments for the research study and 
must not reflect biases during the research, direct the research to the perceived 
understandings,‎or‎control‎the‎participants’‎willingness to participate (Ercikan & Roth, 
2014). Yin (2014) provided‎evidence‎of‎research‎skills‎that‎eliminated‎the‎researchers’‎
biases for the study by (a) relating the questions to the research topic, (b) focusing 
interpretation, (c) predicting flexibility for unplanned happenings, and (d) addressing the 
problem statement throughout the research study. I kept the focus on the problem 
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statement by aligning the research question and the interview questions. I focused on the 
answers of the questions to interpret and analyze data according to the research problem. 
My professional experiences include working in managerial levels of 
pharmaceutical firms in Jordan and some MENA region companies. During this service, I 
participated in interviewing, communicating, and reporting events for CEOs and boards. 
Participants in this research are CEOs and managers from pharmaceutical companies in 
Jordan, which match with my career path. Qualitative researchers must depend on the 
data‎collection‎more‎than‎researchers’‎interpretation‎or‎experiences (Yin, 2014). My role 
in data collection concentrated on the answers of the participants to the interview 
questions. I included the‎CEOs‎interviews‎to‎validate‎the‎managers’‎answers‎and‎mitigate‎
bias. Member‎checking‎is‎the‎method‎that‎confirms‎participants’‎understandings‎from‎the‎
researchers’‎interpretations‎(Harper‎&‎Cole,‎2012).‎I‎used member checking to avoid bias 
and confirm meanings. The research constructs for the case study design include 
triangulation to validate the data collections and minimize bias (Yin, 2014). 
Researchers must observe respect and include explanation of the study purpose, 
protection, confidentiality, and risks included for participation in the study (U.S. 
Department of Health, education & Welfare, 1979). Researchers following of the 
Belmont protocol provided trustworthiness to the participants to maximize benefits for 
participating research studies and‎minimize‎potential‎harms‎of‎participants’‎perceptions‎
(U.S. Department of Health, education & Welfare, 1979). For each participant in this 
study, I observed and provided respect by including and explaining the informed consent 
form contents of voluntary participation. For each participant I treated the information 
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provided ethically, in which I protected the identities to avoid any harm for them. I was 
the only person to keep the records, data, and information for the participants in this 
study and I coded the names and organizations to protect identity in a separate protected 
sheet in my secured computer. I followed Belmont protocol and provided trustworthiness 
to the participants to maximize benefits for participating in this study and minimize 
potential‎harms‎of‎participants’‎perceptions. 
Participants 
Case study design is a qualitative design including the alignment of the research 
purpose with the study participants (Patton, 2015). The selection of the study participants 
to gain an insightful understanding of the event, setting, or plans requires a purposeful 
sample, which was appropriate to collect maximum contextual data (Yin, 2014). Nag and 
Gioia (2012) applied purposeful sampling for their inductive study to scan the top 
management strategy alignment with the execution of changes that implied competitive 
advantages. Bergman et al. (2016) selected 25 participants from seven healthcare setups 
for‎their‎interviews‎purposefully‎to‎characterize‎the‎clinical‎pharmacists’‎inter 
professional collaboration. Yin (2014) listed six possible methods for data sourcing in 
case study design that included interviews, observations, participant-observation, 
artifacts, documentations, and archival records. I applied semistructured interviews for 
CEOs, conduct similar interviews with managers, and review documents to achieve 
triangulation. I applied the member-checking process to validate the data collection in 




theories, which is a triangulation that adds to the study validity (Yin, 2014) 
Jordanian pharmaceutical companies that applied the expansion strategy in 
MENA region are present in Jordan with headquarters in Amman, Naor, Sahab, Al-
Qastal, and Al-Baqaa. To explore the implementation of the expansion strategy in the 
MENA, I selected CEOs from four Jordanian companies and eight managers from the 
same companies of the CEOs. The CEOs are the designers and the decision makers for 
the implementation of the expansion strategy, and managers are the executives of the 
strategy. I selected managers participants according to their (a) involvements in 
expansion strategy in the MENA region, (b) role in implementing expansion strategy, and 
(c) agreement to participate in this study (Irvine, Drew, & Sainsbury, 2012; Vogl, 2013). 
There are 16 working pharmaceutical companies in Jordan, in which 10 
companies’‎products‎are‎available‎in‎external‎markets‎(“JAPM‎- Pharmaceutical 
Industry,”‎2016). I selected four companies, which are implementing the expansion 
strategy in the MENA region. I pooled participants from business developments, strategy, 
sales,‎marketing,‎manufacturing,‎quality‎systems,‎finance,‎and‎supply‎chain‎departments’‎
managers‎for‎the‎managers’‎interviews. I sent participants written details about the study 
before conducting the interviews and discussed the study objectives to build working 
relationship. In addition, all participants received a copy of the Informed Consent Form. I 
informed participants that their involvement in this study is voluntary and confidential. I 
notified the participants that they might withdraw from the study for any reason or not 
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answer any question they might feel uncomfortable to respond according to the Informed 
Consent Form. 
I conducted the interviews after receiving Walden University Institutional Review 
Board (IRB) approval for collecting data. I assured participants’‎protections as human 




position to assure human subject protection, anonymity, and confidentiality. I protected 
the data in softcopies with passwords and data in hard copies in a locked cabinet. I 
prevented third‎party‎access‎to‎the‎raw‎data‎or‎analysis‎without‎the‎participants’‎
knowledge and information. 
Research Method and Design  
This section includes the justification for the use of the research method and 
research design. The justification included the research instruments, population, and 
sampling protocol that I used in this study. 
Research Method 
Qualitative research methods are useful for researchers seeking an in-depth 
understanding of events, skills, or plans; in which numerical data or variables 
construction’s‎relationships‎are‎absent‎or‎unclear‎(Patton,‎2015).‎Practitioner‎researchers‎
and scholars apply the qualitative research methods to identify meanings and 
understandings where quantifiable data measurements or examinations that align with 
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hypotheses are not appropriate (Bevan, 2014). Therefore, insightful exploration for 
collecting data to leverage understanding in contextual formats is not suitable for research 
that deals with data measurements to examine relationships between hypotheses. 
Yin‎(2014)‎noted‎the‎importance‎of‎researcher’s‎interaction with the direct 
environment of the participants to gain adequate understandings of the research problem. 
Expansion strategies implementation is a complex process for pharmaceutical industries 
that required the involvement of multiple managerial, scientific, regulatory, financial, and 
marketing‎entities‎in‎the‎organization‎to‎achieve‎the‎strategies’‎objectives‎(Bowen et al., 
2015; Mastorakis & Siskos, 2016; Srivastava & Prakash, 2014). The research question is 
the aligning research factor for developing interview questions to ask in-depth, open-
ended questions within the research method and the purpose of the study (Marshall & 
Rossman, 2016). 
Pharmaceutical business expansion strategy in companies involve different 
complex approaches and mechanisms for research and‎development‎(R&D),‎products’‎
formulations, marketing positioning, human resources, supply chain management, and 
regulation variation between targeted countries (Bergman et al., 2016; Cantner & Rake, 
2014; Wu, 2013). Lack of standardized expansion strategy between companies is an 
industry differentiation for competitive advantage and positioning (Sarkees et al., 2014; 
Tsokanas & Fragouli, 2012). Measuring the values for the expansion strategy in lacking 
standardized nature of the industry is a challenge for researchers seeking understandings 
of the processes implementation. Therefore, the quantitative method included restrictions 
for the application of the exploration nature of this study. I excluded the quantitative 
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method application for this study, and I applied the qualitative method approach, which 
was appropriate for the purpose of this study. 
Research Design 
Research design selection between qualitative method designs involves evaluation 
of different designs applicability for the purpose of this study. Qualitative research 
designs include ethnography, narrative, and phenomenological for focusing on culture, 
ethnic, and lived experiences of participants (Denzin & Lincoln, 2011). I evaluated the 
qualitative designs for ethnography, narrative, and phenomenological application in the 
complex, dynamic, and variable environment of expansion strategy in pharmaceutical 
industries, which are not appropriate for this study. 
Ethnography is the design that required a study in ethnicities or cultures 
(Williams, 2007) while the purpose of this study is to explore the successful 
implementation of expansion strategy in pharmaceutical industries; therefore, 
ethnography is not appropriate to construct for this study. Similarly, the narrative is the 
design that involves one participant describing lived experiences or event (Denzin & 
Lincoln, 2011). Narrative design is not appropriate for this study purpose because of the 
need to explore more than one participant in different levels of involvement in the 
expansion strategy implementation. Phenomenology is the qualitative design that 
researchers apply to explore an event or phenomenon that affected participants uniformly 
(Bevan, 2014). Although, phenomenology design might seem appropriate construct for 




culture, production capacity, markets orientations, and product positioning. With these 
variations, the expansion strategy might not be a phenomenon of experience among all 
participants. In addition, because of intentional leadership application of the optional 
expansion strategy selection (Mastorakis & Siskos, 2016), the process cannot be a 
phenomenon. Therefore, phenomenology is not an appropriate design for this study. 
Case study design is the qualitative design that includes open-ended interview 
questions‎to‎explore‎participants’‎experienced‎situations‎in‎their‎working‎environment‎
and to identify the ideas of participants that answer the research question (Yin, 2014). 
Case study design includes‎the‎researchers’‎observations,‎semistructured interviews, 
informal explanatory questions, and focus group selection tools for validating the 
findings (Kaczynski, Salmona, & Smith, 2014; Parker, 2014). The‎researcher’s‎role‎is‎to‎
translate the meanings or understandings of‎the‎participants’‎responses‎to‎codes‎and‎
themes (Collins & Cooper, 2014). The case study includes approaches for the 
researchers, which extend the understandings through further informal exploratory 
questions and further member checking to identify, assure, and characterize the core 
concept that the participants experienced (Yin, 2014). 
Expansion strategy implementation for pharmaceutical companies is not identical 
and depends on multiple factors in the business environment (Horner, 2013). Case study 
researchers apply single or multiple cases including the selection between explanatory, 
descriptive, comparative, or holistic approaches, which is appropriate for the answering 
the inductive research question and purpose (Cronin, 2014; De Massis & Kotlar, 2014; 
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Miller & Tsang, 2011). In this study, the appropriate design for answering the research 
question is the multiple descriptive case study design. 
Population and Sampling 
The population for this study included the leaders within Jordanian 
pharmaceutical companies and the executive managers with successful expansion 
strategy implementation. Yin (2014) posited the descriptive multiple case study design as 
an‎appropriate‎setup‎for‎researchers‎with‎participants’‎presences‎in‎the‎same‎setting.‎
Researchers can select the best fitting sample for the case study design to collect data that 
can reach saturation to validate the research design (Covell, Sidani, & Ritchie, 2012). 
Sampling‎application‎is‎the‎researcher’s‎decision‎that‎will assure data saturation, in which 
purposeful, snowball, or focus groups are applicable for census sampling method 
(Robinson, 2014). I applied the purposeful sampling in this study because the purpose of 
this study is to explore the effective application of the expansion strategy. The application 
involved senior‎management‎leaders’‎implementations‎of‎the‎strategy‎in‎the‎Jordanian‎
pharmaceutical companies within the MENA region. Therefore, purposeful sampling is 
an appropriate selection for this study. 
The sample size for the exploration in qualitative studies is smaller than sample 
size in quantitative studies (Marshall, Cardon, Poddar, & Fontenot, 2013). The purpose of 
exploration‎is‎to‎understand‎the‎participants’‎experiences‎from‎the‎data‎collected‎that‎the‎
researcher used from documents, interviews, direct observations, and participant 
observations (Yin, 2014). Therefore, the small sample in case study design is appropriate 
to answer the research question. 
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I selected a sample size of four CEOs of senior management leaders from 
Jordanian pharmaceutical companies because of their effective design and decision 
making‎ process of the expansion strategy in the MENA region. I included a sample size 
of eight senior managers from organizational development department, business and 
strategy departments, operations and supply chain departments, licensing departments, 
and marketing departments. The senior managers were from the same company of the 
CEO that I Interviewed for each selected company. The CEOs and the senior managers 
were from the Jordanian pharmaceutical companies, which was the population of this 
study who are currently implementing the expansion strategy from Jordan through the 
MENA region. 
Participants must be in a current CEO and managerial position with more than 5 
years practicing of strategy implementation. In addition, managers must have more than 
two subordinates and a strategy for expansion in MENA region. I ensured that the 
participants are eligible for this study requirement through signing the Informed Consent 
Form. 
I based the selection of participants on purposeful sampling. Walker (2012) 
described purposeful sampling as an allowance for the researcher to sample a group of 
people intentionally for the best information they can share to answer the research 
question.‎Case‎study‎researcher‎needs‎to‎explore‎the‎participants’‎perceptions;‎which‎
make purposeful sampling appropriate as no probability sampling technique (Richardson, 
2009). I applied the‎sampling‎from‎the‎lenses‎of‎the‎study’s‎conceptual‎framework‎of‎
transformational leadership theory and stakeholder’s theory. 
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Data saturation for the qualitative researcher is the point that the researcher will 
not get new information from purposefully sampled participants; therefore, data 
saturation is the determinant of the purposeful sample size (Walker, 2012). The 
justification of the purposeful sample is important for the qualitative study to ensure 
study validity and reliability (Yin, 2014). The appropriate sample size for case studies 
can range from 5 to 50 participants that would allow the researcher to reach a saturation 
point where no new information, no new theme emerged from participants and the 
replication of the study would give the same results (Dworkin, 2012). I interviewed 4 
CEOs and 8 senior managers from same Jordanian pharmaceutical companies of the 
CEOs that experienced expansion strategy in the MENA region. I defined the data 
saturation point after‎conducting‎the‎seventh‎participant’s‎interview.‎ 
Interviews must include appropriate climate for participants to answer the 
interview questions comfortably or propping questions without interruptions or 
disturbance (Doody & Noonan, 2013). Researchers must provide participants the honest 
and trust feeling including consent to‎answer‎questions‎confidently‎at‎the‎participants’‎
conveniences (Frels & Onwuegbuzie, 2013). I conducted the interviews at the 
participants’‎conveniences‎and‎include‎the‎Informed Consent Form before asking 
questions.‎Conducting‎interviews‎at‎the‎participants’‎headquarters‎offices‎would reduce 
traveling expenses and workplace leavings, which suits face-to-face interview and 
participants’‎connivances‎(Wolgemuth‎et‎al.,‎2015). I requested participants to conduct 
the interviews at their headquarter offices at their convenient time of the working day for 
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about one hour to ensure no interruptions. Similarly, I requested another time for 
conducting the member checking process with each participant. 
Ethical Research 
Human protection in scientific research is critical for the study creditability (Nah, 
Bennett, Ingleton, & Savage, 2013). The protection of human subjects must include 
protection from physiological, psychological, and any harm that might arise because of 
participating in the study, which the international laws enforced for conducting research 
with human subjects (Largent, 2016; Rivers & Lewis, 2014). Walden University 
Institution Review Board (IRB) is the permitting board for conducting research. I 
requested permission from IRB to conduct this study and to collect data from human 
subjects as per Walden University requirements. For each site I selected to conduct this 
study, I received permission from the CEO to allow conducting interviews. After granting 
permission and receiving the Walden University approval number 09-13-16-0426476 in 
the Informed Consent Form, I contacted IRB to approve conducting interviews with 
participants. I applied the following steps: 
1. I requested the CEO to participate in this study. I described the purpose of this 
study and obtained permission to select managers from the same company to 
participate in the study. 
2. I requested the CEO to provide participants according to this study criterion 
for‎managers’‎participation. 
3. I contacted each manager to describe the study purpose, ensure voluntary 
participation, inform participants about ceasing interview at any time, and 
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notify participants of the possibility to cancel an interview after 
commencement. 
4. I advised participants not to answer any question that they may feel 
uncomfortable to answer. 
5. I explained to each participant the identity protection and confidentiality 
method I used in this study before conducting the interview. 
6. I requested participants to sign the Informed Consent Form to ensure 
participants’‎understandings‎of‎this‎study‎purpose and my role in this study. 
7. I did not‎conduct‎any‎interview‎before‎the‎IRB‎approval‎and‎participants’‎
signings of the Informed Consent Form. 
I conducted the‎interviews‎in‎the‎participants’‎workplaces‎for‎obtaining 
convenience and ensure low interruptions during the interviews. I requested approvals 
from each participant to record the interview electronically using my laptop. I coded each 
participant’s‎company,‎position,‎and‎date‎of the interview before saving the records 
electronically. I used numbers and letters to code the recording and provided an 
explanation for the coding in a secured file with password protection. I used multiple 
letters,‎numbers,‎and‎letter‎case‎for‎the‎recordings’‎passwords‎in‎this‎study. 
I protected all recordings using a password saved in my laptop with no access to 
any party without my permission. I treated the raw data of the recording, transcripts, 
identity of participants, and data analysis as confidential records, after completing the 
data analysis, in a separate hard drive protected with password for 5 years from the date 
completion of study. I will destruct the data by deleting files following the IRB 
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requirements. I saved all hard copies in a locked cabinet. No party would be eligible to 
access the raw data, analysis,‎identity,‎or‎hard‎copies‎without‎the‎participants’‎approval.‎I‎
provided no incentives for participating in this study.  
Data Collection Instruments 
Qualitative researchers apply open-ended question, interviews, or questioners to 
collect in-depth data‎about‎the‎participants’‎understandings‎(Yin,‎2014).‎This‎study‎is‎a‎
qualitative case study, in which I served as the instrument for data collection. Qualitative 
researchers are the primary instruments for data collection because the researcher 
prepares the study protocol, asks the interview questions, and records the answers for 
analysis (Cleary, Horsfall, & Hayter, 2014). Semistructured interviews are appropriate to 
collect qualitative data from participants that include an in-depth exploration of the 
applied experiences of the research topic (Boblin, Ireland, Kirkpatrick, & Robertson, 
2013). 
The application of semistructured interviews is useful in case studies to provide 
the researcher with projections to ask correlated researchers question (Yin, 2014). Condie 
(2012)‎described‎the‎researcher’s‎role‎in‎retelling‎participant’s‎information‎during‎the‎
interview and asking clarification as an appropriate tool for more details about 
participant’s‎experiences‎during‎data‎collection‎process. Salih and Doll (2013) used 
semistructured interviews to ask in-depth questions about strategy implementation that 
middle management practiced. Bergman et al. (2016) applied qualitative research to 
study the role of pharmaceuticals in expansion and development of pharmacist-physician 
communication using semistructured interviews. Yin (2014) presented for researchers the 
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requirements for semistructured interviews, which included neutral conversation 
guidance, preparing protocol, adherence to protocol, and prepare to follow up questions. 
I used semistructured interviews in this study to explore the expansion strategy 
implementation in Jordanian pharmaceutical companies. I asked participants to answer 
open-ended questions and record interviews electronically. The questions list is in 
Appendix B. My role as a researcher and data collection instrument was to ask questions 
and further explanatory questions to collect data of the word-of-mouth that participants 
related to the‎expansion‎strategy’s‎understanding.‎I‎interviewed 4 CEOs and 8 managers 
who practiced expansion strategy implementation asking the interview questions for all 
12 participants. For more clarification‎of‎the‎participants’‎responses,‎I‎asked further 
questions if I might find needs to explore more understanding from the participant. After 
receiving the IRB approval number 09-13-16-0426476, I kept conducting interviews until 
I reach to the data saturation point. I defined the data saturation point after conducting the 
seventh‎participant’s‎interview. 
Qualitative researchers interview participants seeking data saturation for the 
study’s‎validity. Data saturation is the point where no more themes arise from the 
interviews, participants repeat answers with no new information, or by repeating the 
interviews using the same construct same results would appear (Fusch & Ness, 2015). 
Walker (2012) posited that data saturation is important to ensure research data quality 
and maintain credibility. Byrne, Brugha, Clarke, Lavelle, and McGarvey (2015) argued 
that experienced, trained, and familiar researchers are capable of collecting quality data 
70 
 
from peer interviews, in which researchers’ understandings and challenging supported 
data adequacy. 
I interviewed CEOs and managers from pharmaceutical industry who 
implemented expansion strategy in MENA region. My profession in the pharmaceutical 
industry was a tool that facilitated interpretations‎of‎participants’‎answers‎to‎the‎interview‎
questions and allowed further clarification on the topic. The data saturation point of the 
data collection in this study was after no new themes indicated from participants’‎
responses. I‎defined‎the‎data‎saturation‎point‎after‎conducting‎the‎seventh‎participant’s‎
interview. I used member-checking technique to ensure that my interpretations match 
with‎the‎participants’‎understandings‎of‎the‎expansion‎strategy‎implementation. 
Data Collection Technique 
I requested all participants to sign the Informed Consent Form before conducting 
the interviews. For the CEOs, I phoned each CEO and ask for an appointment to conduct 
the interview. Before the CEOs interview, I handed a printed copy of the interview 
questions for each participant to review and decide voluntarily to conduct the interview. 
The interview time ranged between 35 to 50 minutes. I requested the CEO to appoint 2 to 
4 managers from the company to participate in this study and to provide their emails. 
Accordingly, I sent emails of the question to the managers to review and prepare for the 
interviews. I conducted the‎interviews‎in‎the‎company’s‎offices‎for‎more‎convenience‎of‎
the participants, and I requested no interruptions during the interview. I indicated for all 





observations, and enhance understanding (Allwood, 2012; Marshall & Rossman, 2016). 
De Massis and Kotlar (2014) stressed for case study researchers to conduct interviews 
with an emphasis on the conceptual framework for rigorous study findings, which must 
guide the open-ended questions, observations, note taking, data collection, data analysis, 
and interpretations. Recording interviews is a technique that qualitative researchers used 
to take notes, view participants, and keep the interview track with the protocol (Jacob & 
Furgerson, 2012).  
Methodological triangulation is used in qualitative research to correlate multiple 
data‎sources‎for‎rich‎data‎collection‎technique,‎which‎validated‎themes‎findings‎(O’Reilly‎
& Parker, 2013). Member checking is an assurance of researcher interpretation of the 
data collected, which adds to the study’s‎validity (Yin, 2014). I applied the 
methodological triangulation by conducting interviews with CEOs, interviewing 
managers for the expansion strategy implemented in the company, and reviewing 
documents. I asked CEOs form each company to provide the document for the 
company’s‎financial‎statement‎that‎includes‎profit‎and‎loss,‎cash‎flow,‎and‎expansions‎
achievements, which was the documentation data instrument for this study. I applied 
member-checking methodology before data analysis process to confirm my analysis of 
participants’‎responses. Case study researchers applied methodology triangulation 
through collecting qualitative data from multiple interviews, observations, and 
documents’‎reviews,‎or‎websites contents including member checking to collect rich data 
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for rigorous design (Bekhet & Zauszniewski, 2012; Culpin & Scott, 2012; González-
Ferrer & Peleg, 2015; Stephansen & Couldry, 2014).  
Coding the recording for the interviews of each participant is an appropriate 
method for maintaining confidentiality and anonymity (Gibson, Benson, & Brand, 2012). 
I coded the recordings with alphabetic and numeric characters and verbatim each 
interview manually from the recordings. The manual verbatim process is advantageous 
because the researcher might gain‎more‎understanding‎of‎participants’‎replies‎during‎the‎
verbatim but the process would take time for all participants (Page & McDonnell, 2015). 
I applied the keywords in context (KWIC) to code the transcripts of the‎participants’‎
answers for this study. KWIC is an appropriate method for analyzing qualitative data and 
form the coding of transcripts, which researchers need to understand meanings and assign 
studies’‎themes‎(Onwuegbuzie, Leech, & Collins, 2012). 
Data Organization Technique 
Keeping raw data and data analysis organized is the responsibility of researcher, 
which would support data retrieval and enhance credibility (Schermann et al., 2014). 
Data organization includes assigning file names for stored data with noticeable 
identification for references and content (Sayogo & Pardo, 2013; Wickham, 2014). 
Qualitative data organization include videos, audios, notes taking, observations, and 
documents, which imply proper data storage that would satisfy ethical, confidential, and 
security requirements for human subjects protection (Largent, 2016). 
In this study, I assigned alphabetic‎and‎numerical‎file‎names‎for‎the‎interviews’‎
recordings. The first character indicated for the site that I visited; the second character 
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was numerical‎in‎serial‎for‎the‎participants’‎interviews,‎and‎the‎third‎was a character for 
differentiating CEOs from managers. For example, A05C indicated for company A, 
participant number five, and a CEO. I recorded interviews using HP laptop PC and store 
the files in a specific folder for this study named study interviews with password 
protection. The raw data storage served the data analysis, in which I used the coded 
names for Mindjet program that I used. I maintained the electronic data storage, data 
analysis, and electronic documents for the next 5 years from the date of the completion of 
the study and CAO approval. Similarly, I stored printed materials of the raw data in a 
locked cabinet for 5 years from the date of CAO approval. 
Data Analysis 
Data analysis is the method that qualitative researchers apply to obtain results for 
the research problem using theories, conceptual framework, and appropriate qualitative 
analysis techniques (Yin, 2014). Onwuegbuzie et al. (2012) provided multiple analytical 
tools that researchers applied in qualitative research, which researchers aimed for quality, 
credibility, validity, and reliability of the research. The qualitative data analysis includes 
step-by-step manual data analysis formulation using conventional methodologies or 
computer based programming that applied computer-assisted qualitative data analysis 
software (CAQDAS) (Yin, 2014). Mind mapping is an analytical tool for qualitative data 
analysis that researchers applied to identify themes within the conceptual framework of 
the research (Webster et al., 2013). 
I asked the interview questions (see Appendix B) and record the answers 
including manual note taking during each interview. Transcription of the interviews was 
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by manual re-play of the recording and typing of the answers. I requested participants to 
speak in English if more comfortable to express understanding than Arabic. If Arabic 
conversation evolved, I did not stop participants and keep recording. For Arabic answers, 
conversation, or partial answers, I employed an authorized translator. The authorized 
translator used my transcripts and coded recordings to approve translations. I collected all 
English transcripts of each participant in Microsoft Excel spreadsheets. For each 
question, I had re-written the answer and re-read the contents to be familiar with the text, 
which qualitative researchers recommended for better understanding of the context within 
the conceptual framework of the research (Lindberg, von Post, & Eriksson, 2013; 
Onwuegbuzie et al., 2012; Webster et al., 2013). 
Marking the keywords is appropriate for qualitative data analysis, which must 
align‎with‎the‎conceptual‎framework‎of‎the‎study‎(Baškarada,‎2014;‎Guest,‎Macqueen,‎&‎
Namey, 2012; Todorova, 2014). I used coloring text method (Dul & Hak, 2012) that 
relate‎to‎transformational‎leadership‎and‎stakeholders‎in‎the‎participants’‎transcripts‎
answers within the Excel spreadsheets. I organized the coded text in adjacent columns to 
the answers’‎texts and code the colored text of each answer based on transformational 
leadership and stakeholder theories. I collected the codes in another column with 
summaries from all answers. From the emerged columns of the codes, I identified 
common themes and initiate a link, relationship, and connection between the themes.  
Mind mapping technique is a tool for visualizing links, connections, and 
relationships between the coded notes from the transcripts that qualitative researchers 
applied for data analysis (Awad‎&‎Hegazy,‎2015;‎Balım,‎2013;‎Guerrero‎&‎Ramos,‎2015;‎
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Nakrem, Vinsnes, Harkless, Paulsen, & Seim, 2013). I used Mindjet software as a mind 
mapping ‎ tool to group coded texts and themes from the Excel spreadsheets and connect 
with labeling the relationships between the groups for each question and each participant. 
I included in Appendix C the Mindjet map of the relationships between the themes from 
the conceptual framework of this study. Webster et al. (2013) used Mindjet software to 
connect the study-coded findings and arrange the themes for discussions. Similarly, 
Nakrem et al. (2013) applied Mindjet software to connect relationships between coded 
text and initiate themes for the research findings. 
Categorizing, connecting, and comparing the codes from‎participants’‎answers are 
part of the qualitative analysis of the study findings, which includes rearrangement, 
summarizing, filtering, and identifying major themes to confirm results (Bevan, 2014; 
Onwuegbuzie et al., 2012; Yearworth & White, 2013). The emerging themes from the 
data analysis are the sources for the study results that the researcher needed to confirm 
findings by comparing, developing, or disclosing new themes by addressing other studies 
and literature of the field of the research (Dadfar, Dahlgaard, Brege, & Arzaghi, 2014). I 
analyzed the emerging themes from this study according to the literature review and the 
conceptual framework. I compared the results with recent studies in expansion strategy 
implementation and provided the reader a comparison between this study results and 
other studies in the literature. 
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Reliability and Validity 
Reliability 
Qualitative researchers prove the realistic and trustworthiness of the data collected 
from real participants by addressing study reliability (Elo et al., 2014). The research 
quality includes an emphasis on the data bias, which qualitative researchers address to 
indicate for quality research (Marshall & Rossman, 2016). Yin (2014) determined the 
setup for quality research for the case study design by triangulation, which included data 
collection, methodology, or conceptual framework. I applied member checking and 
documents’‎reviews methodological triangulation for the reliability of this study.  
Member checking, as a construct of reliability, is the process that researchers 
apply for the assurance about the interpretation of the participants’ answers to confirm 
realistic and accurate interpretation of the raw data collected for the dependability of the 
study (Marshall & Rossman, 2016). I applied member-checking procedure for this study. 
After conducting the interview, I scheduled for another member checking time with each 
participant and‎inform‎about‎each‎question’s interpretation. If my interpretation is not 
similar to the participant’s understanding, I clarified the meanings and re-write the 
interpretation. 
Methodological triangulation is important for study reliability, which includes 
different data sources to support the triangulation requirement for the dependability of the 
study findings on the data analysis method employed (Denzin & Lincoln, 2011). I asked 
the‎same‎question‎in‎the‎interviews‎for‎organizations’‎leaders (i.e.: 4 CEOs) and the 
strategy implementers (i.e.: 8 managers) and reviewed the documents of the financial 
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statements for each company, which were multiple sources of data collection for this 
study. The analysis of the data in qualitative research includes and is a requirement for 
the synthesis of the meanings that participants disseminated to add value to the 
statements (Marshall & Rossman, 2016). I combined the analyzed codes from the 
participants’‎answers‎and‎arrange‎in groups to collect the themes from the process, which 
is a procedure to gain rich data and attain reliability (Yin, 2014). I followed the 
procedural data analysis in this study with clear mentioning of the results at each step to 
provide other interested readers details for re-analyzing to get same results. This 
procedure included the dependability of the results on the methodology I employed for 
this study. 
Validity 
Qualitative research validity is a confirmation of accuracy in conducting the 
study, collecting data, analyzing data, and confirming findings (Houghton, Casey, Shaw, 
& Murphy, 2013). Qualitative case study validity includes appropriate sample selection 
for the study that confirms with the purpose of the study (Cronin, 2014). Validity in case 
study design is a rigorous indicator for the researcher involvement in the data collection 
and analysis that the researcher must provide for readers (Unluer, 2012). 
I selected purposeful sample for this study from CEOs and managers with 
expansion strategy implementation in Jordanian pharmaceutical companies, which 
confirms with the validity of the case study through methodology triangulation for 
confirmability. The purposeful sample is an appropriate selection to attain case study 




purpose for better understanding, which confirms with credibility. I applied member-
checking procedure‎for‎accurate‎interpretation‎of‎the‎participants’‎answers.‎Member‎
checking is a confirmation of the study validity that authenticates the intention of the 
research and provides rigor construct for analysis (Vaismoradi, Turunen, & Bondas, 
2013), which includes study credibility. I applied the member-checking process to 
achieve the study credibility. 
Data saturation is a validity construct of qualitative research, which confirms with 
sampling application that will assure data saturation (Robinson, 2014). Data saturation 
for the qualitative researcher is the point that the researcher will not get new information 
from purposefully sampled participants; therefore, data saturation is the determinant of 
the purposeful sample size (Walker, 2012). The justification of the purposeful sample is 
important for the qualitative study to ensure study validity (Yin, 2014). I applied the data 
saturation in this study. Data saturation point is the point that no new information 
emerged, no new theme emerged from participants, and the replication of the study will 
give the same results (Dworkin, 2012). After the seventh interview in this study, next 
participants did not add new information or themes, which I considered as the data 
saturation point for this study. 
Transferability is a research validity that includes application in the different 
construct of the site of the research, which indicates for generalization of the findings 
depending on similarities or differences between sites (Duggleby & Williams, 2016). 




purpose of this study is applicable for Jordanian pharmaceutical companies with 
expansion strategy implementation in MENA region. Therefore, I did not generalize the 
findings to other contexts for this study. 
Transition and Summary 
The purpose of this qualitative descriptive multiple case study is to understand the 
implementation of expansion strategy of Jordanian pharmaceutical companies in MENA 
region by applying Yin (2014) construct and analysis of case study design. I used 
semistructured and electronic recorded interviews to collect data to explore strategies and 
participants’‎perceptions. I triangulated the data collection from multiple sources 
including member-checking procedure to ensure study validity and reliability. I applied 
purposeful sampling technique of professional pharmaceutical managers in Jordanian 
companies, which practiced expansion strategy in MENA region. I requested from 
Walden‎University’s‎IRB‎approval‎for‎conducting‎the‎research, and I did not collect data 
before obtaining IRB approval. I conducted face-to-face interviews with all participants, 
record interviews electronically, and transcript verbatim of the recordings. I applied the 
data analysis using KWIC method and follow the themes and patterns emergence for this 
study.  
In Section 2, I included and discussed the research methodology, study purpose, 
role of the researcher, participants and sample size, research method and design, data 
collection, and data analysis. I ended Section 2 with discussions for the validity and 
reliability of the study. Section 3 includes the presentation of findings, application to 
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professional practice, the implication for social change, recommendation for action, and 
future study. I ended Section 3 with the summary and conclusion. 
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Section 3: Application to Professional Practice and Implications for Change 
Introduction 
The purpose of this qualitative descriptive multiple case study was to explore 
effective application of expansion strategy among Jordanian pharmaceutical managers ‎to 
satisfy the demand in the MENA markets. The ‎specific business problem was that some 
Jordanian‎pharmaceutical‎companies’‎‎managers ‎lack the effective application of 
expansion strategy ‎to satisfy the demand in the MENA markets. I applied a purposeful 
sampling technique of 12 participants from professional pharmaceutical managers in 
Jordanian companies, which practiced expansion strategy in MENA region. 
The data collection method that I used in this study was face-to-face 
semistructured interviews and financial statements review of each participant’s company. 
Triangulation included transcript reviews of the recorded interviews and data from the 
financial statements (Yin, 2014). I reached the data saturation point after receiving no 
new‎theme‎from‎the‎participants’‎answers,‎which I found with the seventh participant in 
this study. In Excel spreadsheets, I collected‎the‎participants’‎answers‎for‎each‎question‎
and identified the keywords to code the context. By collecting the codes and the repeated 
keywords from the answers, I identified the links between the questions numbers and the 
answers using the Mindjet software as a mind mapping ‎ tool to group coded texts. The 
emerged themes from this study were leader’s adaptability to change, financial capacity 
and stability, stakeholders’ business‎awareness,‎and‎managers’‎engagement‎and‎
knowledge. I received some recommendations from the participants that were related to 
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the last question for sharing information about the effective application of the expansion 
strategy in Jordanian pharmaceutical companies.  
Presentation of the Findings 
The overarching research question for this study was what strategies do Jordanian 
pharmaceutical managers apply for effective business expansion ‎to satisfy the demand in 
MENA markets? The analysis of the data collected from the semistructured interviews 
and the financial statements reviews included the identification of the findings to answer 
the research question. I considered the data saturation, after I received repetitive 
information from participants that could not add new information to the collected data. I 
defined‎the‎data‎saturation‎point‎after‎conducting‎the‎seventh‎participant’s‎interview.‎The 
findings from this study were the emerging four themes, which I related to the conceptual 
framework for the transformational leadership and the stakeholders theory. 
The maximum data collection was from the semistructured interviews with 
participants. The second source of data was from the financial statements of the 
participants’‎companies,‎which‎I related to the cash flow and profit and loss statement. 
After transcription of the interviews, I emailed participants the summary of the answers 
including my interpretation to confirm with the member checking requirements of the 
study design. After receiving the confirmation from participants, I applied the KWIC 
process‎to‎define‎the‎codes‎from‎participants’‎answers‎to‎the‎interview‎questions. I 
formed a mind mapping structure for the codes using the Mindjet program. By 
connecting the codes from the answers and relating codes from different questions 
including the financial statements codes, I defined the themes from the transformational 
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leadership theory and stakeholders’‎theory.‎The‎four‎themes‎were‎leader’s‎adaptability‎to‎
change,‎financial‎capacity‎and‎stability,‎stakeholders’‎business‎awareness,‎and‎managers’‎
engagement and knowledge. 
The first theme emerged in this study was the successful‎leader’s‎adaptability to 
change as a response to the turbulence of economics in the MENA region. The second 
theme was the financial capacity and stability that shareholders and‎ leaders apply to 
successful implementation of the expansion strategy. The third theme was the different 
stakeholders’‎business‎awareness‎of‎the‎pharmaceutical‎industry‎in‎MENA.‎The‎forth‎
theme‎was‎about‎the‎importance‎of‎managers’‎engagements and knowledge about the 
expansion strategy implementation. I aligned the four themes with the transformational 
leadership‎theory‎and‎the‎stakeholders’‎theory. Figure 2 is an illustration for the themes 
emerged and the conceptual framework for this study.  
 
Figure 2. Themes and conceptual framework. 
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Emergent Theme 1: Leader’s Adaptability to Change 
The first theme emerged from this study included the adaptability to the changes 
that leaders are practicing in implementing the expansion strategy in MENA. The 
changes, according to participants, are important because of the prevailing instability in 
the region including the economical turbulences, currency devaluations, changes in 
regulations for registrations, and enforcements of intellectual property rights (IPR) in 
MENA. These multiple external factors affected the internal adaptability of the 
organizations that included the requirements from leaders to develop understandings to 
comply‎with‎the‎markets’‎demands‎and‎changes.  
According to participants, leader’s effective application of the transformations 
included effective communications of the changes that will reflect an effective 
competitive advantage. The responses included developments of organizational values for 
research and developments, business-to-business collaborations, training for human 
resources, and strengthening the internal registration departments. Participants mentioned 
that changes introductions because of the expansion strategy must align with the internal 
production capacity and customers increasing demands. The effective application of the 
balancing and‎alignment‎included‎leader’s‎ability‎to‎motivate‎and‎promote‎for‎the‎
expansion benefits. Figure 3 is for the Mindjet file for the codes I collected and the 




Figure 3. Mindjet illustration of the emerged Theme 1. 
The emerged theme of leaders’‎adaptability‎to‎changes‎is‎in‎alignment‎with‎the‎
transformational leadership theory. The transfer for implementation is the short-term 
planning, implementations, and control, which are the management's responsibility that 
manifests the understanding of the enterprise level strategy (Elving  et al., 2012). The 
complexity of the information and the level of the uncertainty involved the efficient 
strategy streamline performances with appropriate communication of the enterprise level 
strategy for implementation (Montalban & Sakinç, 2013). Leaders with transformational 
style are adaptable to changes through transforming organizational capacities that will 
respond to the markets changes for competitive advantages (Dixit & Yadav, 2015).  
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Transformational leadership is the leadership style that leaders apply to introduce 
changes through motivations (Northouse, 2013).‎Managers’‎and‎subordinates’‎
personalities, awareness, and culture alignment with organizational values is the leaders’ 
responsibility that introduces the appropriate change for strategy implementation (Donate 
& Sánchez de Pablo, 2015). Knowledge management practices that leaders apply in the 
organization motivate the acceptance to adapt changes for strategy implementation 
(Ahmad et al., 2014). Abraham, Morin, Renaud, Saulquin, and Soparnot (2013) found a 
significant‎relationship‎between‎knowledge‎experts’‎expectations‎from‎applying‎changes‎
and effective motivations that leaders applied.  
Emergent Theme 2: Financial Capacity and Stability 
The second theme emerged in this study was financial capacity and stability for 
the expanding companies in MENA. Participants in this study mentioned the financial 
ability of the organization and the financial management as a major factor for the 
successful implementation of the expansion strategy. The financial records and 
statements for the expanding companies included cash flow generations from the new 
markets in MENA that involved profitable achievements. In addition, the investment 
plans included requests for capital increases to align with the expansion strategy. The 
investments plans included funds allocations for marketing and sales plans in the areas 
that the companies are expanding in for the MENA, which is a requirement for effective 
business competitiveness. Participants explained the financial allocations for the 
strategies implementation as a major factor for the effective implementation of the 
expansion and the financial statements confirmed the mentioned points of the 
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participants. Figure 4 is for the Mindjet file for the codes I collected and the emerged 
Theme 2. 
 
Figure 4. Mindjet illustration of the emerged Theme 2. 
The emerged theme of financial capacity and stability is in alignment with the 
stakeholders’‎theory‎of‎the‎conceptual framework of this study. The primary stakeholders 
in the expansion strategies are the investment sectors and the shareholders, for which 
return on investment and increasing revenues are the key values for increasing the 
financing of the expansion strategies of the pharmaceutical organizations (Tripathy & 
Prajapati, 2014). Participants in this study indicated for the important implementation of 
the‎financial‎plans‎in‎alignment‎with‎the‎leaders’‎understandings‎of‎the‎MENA‎
challenges. Major challenges mentioned by participants included the MENA local 
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authority’s protection for the local manufacturers, which implied changes in the 
investment plans from sales expansions to collaborations expansion with targeted 
countries’ local manufacturers. Such choices for expansion included risks of high 
competition with multinationals that leaders must formulate a strategy to mitigate the 
competition’s effect.  
Pharmaceutical companies are examples of leadership resilience in the 
challenging business and regulations environment because of new discoveries, financial 
crises, generic introductions, intellectual property rights, good manufacturing practices 
(GMP) development, and increased cost of innovation and development (Fisher, 
Cottingham, & Kalbaugh,‎2015).‎Leader’s style, stakeholders‎including‎shareholders’‎
orientation, knowledge, encouragement, and motivation were fundamentals for 
pharmaceutical companies to maintain competitiveness and existences, which contributed 
to innovative business models (Aslam, 2015). Such business models were introductory to 
mergers, acquisitions, licensing, technology transfer, franchise, innovation outsourcing, 
and products development (Michelino, Lamberti, Cammarano, & Caputo, 2015; 
Nishimura & Okada, 2014; Srivastava & Prakash, 2014; Wang & Li-Ying, 2014). 
Emergent Theme 3: Stakeholders’ Business Awareness 
The third‎theme‎emerged‎in‎this‎study‎was‎the‎stakeholders’‎business‎awareness‎
for the expanding companies. Pharmaceuticals manufacturing companies involve 
scientific approaches to develop the business models of the expansion strategy 
(Nagurney, Li, & Nagurney, 2013). In addition, the pharmaceuticals industry is a 
regulated industry by the local and targeted countries authorities (FDA, 2001). 
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Participants in this study stressed for the successful implementation of the expansion 
strategy‎through‎the‎awareness‎that‎the‎stakeholders‎gain‎from‎the‎organizations’‎
activities and targets. The participants mentioned the stakeholders of the organizations 
mainly as the shareholders, employees, regulatory, customers, and agents including the 
remote communities in MENA.  
The awareness of the shareholders included different levels for the expansion 
strategy activities of (a) guidance to the management, (b) financial support, (c) approvals 
for investments, and (d) accountability. The‎employee’s‎awareness‎included‎the‎
understanding of the expansion strategy from the gained experiences and the regulations 
requirements,‎which‎maximized‎the‎employees’‎involvements‎for‎the‎decision making‎ 
processes and successful implementation of the expansion strategy. MENA countries’‎
regulations, according to the participants, included lack of uniformed requirements for 
registration. Therefore,‎the‎product’s‎dossier‎registration‎processes‎is changing from one 
country to another, which included multiple costs and investments values. Participants 
stressed that regulation authorities in MENA are not aware of the cost involved in the 
multiple requirements and the different requirements from one country to another. The 
participants found expansion in European Union (EU) countries more clear in 
requirements than MENA. The intellectual property rights regulations enforcements in 
MENA included restrictions for the generic producers in the region. Therefore, licensing, 
technology transfer, know how sales, mergers and acquisitions, and collaborations were 




Agents and customers are another stakeholders mentioned by the participants in 
this study. The awareness for the expansion strategy by the agents and customers 
included the acceptance, support, and facilitation for registration. The agents and 
customers’ awareness of the expansion strategy included increases in sales and profits. 
The increase in sales and profits is critical for the financial performances of the 
organizations’‎cash‎flow,‎according‎to‎the‎financial‎statements‎of‎the‎participants’‎
documents. Figure 5 is for the Mindjet file for the codes I collected and emerged Theme 
3. 
 
Figure 5. Mindjet illustration of the emerged Theme 3. 
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The emerged theme of stakeholders’‎business‎awareness‎is in alignment with the 
stakeholders’‎theory‎of‎the‎conceptual‎framework‎of‎this‎study.‎Customers, shareholders, 
employees, regulatory authorities, and society members are the affected parties of the 
organizations’‎performances in addition to remote MENA communities of unanticipated 
stakeholders, which are potential for the organization if communicated effectively for 
expansions activities interests (Mitchell, Van Buren, Greenwood, & Freeman, 2015). 
Technological advancement and accessibility are one of the millennium globalization 
tools for searching and defining interests that potential stakeholders apply to gain 
knowledge‎about‎organizations’‎performances‎(Tsai‎&‎Bagozzi,‎2014).‎Mitchell et al. 
(2015) found stakeholders in the expansion strategy as critical communication factor for 
the implementation that includes the expectations of the affected parties due to the 
expansion activities. Therefore, stakeholders’‎awareness‎for the expansion strategy is 
primitive for effective strategy implementation. 
Stakeholders including the ‎shareholders must benefit from the pharmaceutical 
organization’s business expansion ‎performance that enhances the leadership direction to 
extend‎the‎managers’‎‎understandings‎of‎the‎stakeholders’‎impacts‎(Kazadi et al., 2015). 
The primary stakeholders in the expansion strategies are the investment sectors and the 
shareholders, for which return on investment and increasing revenues are the key values 
for increasing financings of the expansion strategies of the pharmaceutical organizations 
(Tripathy & Prajapati, 2014). Pharmaceuticals manufacturing leaders leveraged the 
competitive business advantages by maximizing the conversion value, lowering the costs, 
first to serve the markets, and increasing the customer care efficiencies (Bartlett & 
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Ghoshal, 2013). These processes improved information flows and application to create 
the focus on the stakeholders’‎values‎leveraging.‎Such‎values‎secured‎the‎sustainability‎of‎
the organization and provided the strategic competitive advantage that human resources 
were a fundamental factor for advancement (Bartlett & Ghoshal, 2013).  
The practical implementation of the sustainable strategy includes defining the 
primary success factors for the analysis of the prevailing environmental factors 
(Lindgren, 2012). In addition, Lindgren included the capabilities of the organization that 
satisfied‎the‎customers’‎long-term loyalty as a sustainable strategy for implementation, in 
which the value chain of the organization reflected sustainability. Focus approach is a 
successful way of identifying the primary success factors for pharmaceutical companies, 
in which the strategy formulators balance the internal resources and external demands to 
sustain‎the‎value‎objectives‎of‎the‎enterprise’s‎long-term existences (Tatham & Spens, 
2011; Teirlinck & Spithoven, 2013). Therefore, involving stakeholders in the expansion 
strategy‎is‎critical‎for‎organization’s‎sustainability. 
Stakeholders are the directors of the organization activities and performances. 
Freeman's‎(2010)‎definition‎of‎stakeholders‎depended‎on‎organizations’‎interactions‎
within the business environments, which include parties from internal and external 
surroundings of the organization. Freeman extended the affected parties to include 
governments, competitors, suppliers, employees and regulatory parties. The 
organizations’‎activities‎involve‎changes, benefits, and developments, in which social 




The leaders of the organization deliver the long-term‎achievements’‎requirements‎
that fulfill the vision, mission, and values to the lower levels of the organization for 
implementation. The transfer for implementation is the short-term planning, 
implementations, and control, which are the management's responsibility that manifests 
the understanding of the enterprise level strategy (Elving et al., 2012). The complexity of 
information and the level of the uncertainty determine the efficient strategy streamline 
performances, in which complex information and high uncertainty require effective 
enterprise level strategy implementation (Montalban & Sakinç, 2013). The decrease in 
complexity and uncertainty will downstream the strategy to corporate, business, and 
functional level strategies that deal with more confirmed information and certain 
processes and procedures (Andries et al., 2013). Kottke et al. (2013) found employees 
with‎no‎confidence‎in‎leadership‎would‎not‎accept‎leadership’s‎ideas,‎which‎resulted‎in‎
low‎score‎employees’‎performances,‎employees‎tended‎to‎sabotage‎leadership‎strategy,‎
and conflict of interest was a cause‎for‎employees’‎confidences‎lack‎in‎leadership.‎
Therefore, acceptance of change is a generation of leadership style and followers 
perceptions that include mutual understanding and benefits. 
Stakeholders’‎decisions‎may affect the resources allocation that organizational 
leaders require for effective strategy implementation. Scheibehenne, Rieskamp, and 
Wagenmakers (2013) provided theoretical framework using Bayesian inference technique 
that uses beliefs and behaviors of individuals to determine the actions that individuals 
make. Scheibehenne et al. (2013) indicated for the application of the model for the 
expansion strategy, which could apply to the stakeholders as the primary influencers for 
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the organization resources facilitation to understand the forces driving the decision 
making‎ processes. Such forces might not include monetary benefits only but extend to 
social, environmental, and pride values that the supply chain management, investment, 
and purchasing behaviors of stakeholders control the organization activities and 
expansion decisions for sustainable performances (Wolf, 2014). Therefore, knowing the 
stakeholders‎influencing‎needs‎is‎critical‎for‎organizations’‎leaders‎to‎implement‎the‎
expansion strategy effectively. 
Expansion strategy implementers are the managers in the organization. These 
managers convert the strategy initiative into monetary values that the stakeholders 
evaluate as returns on investment (ROI), which is the primary key performance indicator 
(KPI) for the leaders and managers in the organization (Vallejo & Wehn, 2016). The 
expansion strategy implementation includes stakeholders’ values fulfillment for ethical 
performances of the ROI (Hahn & Lülfs, 2013). Analytical application of the expansion 
strategy effectiveness for stakeholders’‎values is critical for the expansion strategy, which 
indicates for the benefiting parties from investments and controls negatively affected 
parties within the organizations’ activities (Öberseder, Schlegelmilch, & Murphy, 2013). 
Therefore, managers in expansion strategy implementation must acquire the stakeholders’‎
ethical values for effective strategy implementation.  






the‎organizations’‎hierarchies.‎The‎participants‎mentioned‎experienced managers in the 
expansion strategy as a major implementers and contributors to the strategy designs, 
which the organization mission and vision statements included. Participants posited that 
engagement of managers in the expansion strategy designs facilitated the appropriate 
implementation and raised the awareness for the requirements particularly in MENA 
turbulent‎markets.‎The‎compliance‎requirements‎for‎the‎products’‎dossiers,‎the‎marketing‎
effectiveness, the deliveries of products, and production requirements were 
responsibilities for‎the‎departments’‎managers’‎for‎implementing‎the‎expansion‎strategy,‎
according to participants in this study. 
Participants’‎answers‎for‎the‎managers’‎qualifications‎and‎abilities‎included‎the‎
importance of acceptance of ideas from others, low resistance to change, organizational 
culture, team working, collaboration with external parties, and flexibility. Some 
participants applied the balanced score cards (BSCs) system for the evaluation of the 
performances and task distribution that involved managers’‎engagements and 
implementations.‎The‎KPIs‎are‎other‎systems‎for‎evaluation‎of‎the‎managers’‎
contributions for the expansion strategy according to some participants. Participants 
mentioned the importance of training and continuous education as appropriate tools for 
managers’‎improvements‎to‎increase‎the‎expansion‎strategy‎effectiveness. Figure 6 is for 
the Mindjet file for the codes I collected and the emerged Theme 4. 
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 Figure 6. Mindjet illustration of the emerged Theme 4. 
The emerged theme of managers’‎engagement and knowledge is in alignment 
with‎transformational‎leadership‎theory‎and‎stakeholders’ theory of the conceptual 
framework for this study. Expansion strategy in organizations is a development process 
that includes innovation and creativity. Transformational leader practices initiations and 
supports innovation and creativity, which is a critical change for competitive advantage 
(Schriber & Löwstedt, 2015).  
Burgess (2013) found critical relationship between communication style 
management and leader’s‎decision‎maker,‎which‎formed‎advancements‎due‎to‎sharing‎
and engaging of strategy implementers in decision making‎ processes for the organization. 
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Transformational leaders apply engagement practices that the communication, trust, 
motivation, and awareness are functional processes for developing mutual understandings 
for‎the‎sustainable‎organization‎in‎competitive‎business‎markets‎(Men,‎2014).‎Leaders’‎
understandings of followers are significant in decision making‎ practices that leaders 
needed to introduce changes and leverage performance (Kottke et al., 2013). Leaders 
must‎acquire‎the‎business‎as‎well‎as‎behavioral‎influences‎to‎develop‎followers’‎
knowledge that target the learning processes in the organizations to the advancement and 
competitiveness (Epitropaki, Sy, Martin, Tram-Quon, & Topakas, 2013). Competent 
leaders can forward influences in the organizational structure that the business 
environment is changing because of external factors affecting organization performances 
(Parnell, Lester, Long, & Köseoglu, 2012). Leaders in such conditions are the finders of 
the‎required‎effective‎performances‎that‎maintain‎organizations’‎existence,‎particularly,‎
during a crisis or changing regulations (Petrou, Demerouti, & Häfner, 2015).  
The leaders focus must include appointing capable managers for the expansion 
strategy in the right strategy task, in which managers align the effect of the 
implementation of the strategy and organization objectives actively (Akhavan & 
Pezeshkan, 2014). Managers as strategy implementers need to understand the actions and 
initiatives that link with organization values, cultures, and objectives for better 
performance in the strategy execution (Green, Albanese, Cafri, & Aarons, 2014). 




awareness, defining proper research about the business model, logic application, and 
cultural differences.  
Leaders’‎knowledge‎about‎the‎managers’‎styles‎and‎thinking‎practices‎is‎a‎
requirement for the application for appointing managers for strategy implementation. 
Successful strategy implementation is a process that requires the utilization of business, 
technical, and managerial competencies. Liang, Howard, Koh, and Leggat, (2013) studied 
the‎critical‎managers’‎competencies‎that‎managers‎must‎acquire‎to‎deliver‎organization’s‎
objectives. Liang et al. (2013) accounted for interpersonal communication qualities, 
operations’‎resources‎management, leading change management, and decision making‎ 
management as primary competencies for managers to achieve the strategy objectives in 
organizations.‎Trong‎Tuan‎(2012)‎found‎a‎significant‎relationship‎between‎managers’‎
transformational behavior and business targets effectiveness, which improved business 
outcomes and advanced organization image. Managers in advancing business 
effectiveness in organizations must combine technical and business qualification that 
leverage‎the‎stakeholder’s‎interest‎and‎attain‎business profitability (Miles, 2012). In 
addition,‎the‎organization’s‎business‎performance‎is‎a‎stakeholder’s‎interest,‎which‎
managers maintain for effective business expansion and sustainability. 
Practitioners’‎and‎scholars’‎studies‎in‎pharmaceutical‎industries included 
innovation‎competencies‎that‎managers’‎apply‎to‎leverage‎edge‎for‎competitive‎
advantages (Epitropaki et al., 2013; Hu, McNamara, & McLoughlin, 2014; Kim, 2014; 
Montalban & Sakinç, 2013; Pollock, 2014). The innovation practices in pharmaceutical 
industries included introductions of business models for expansion strategy to enhance 
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business effectiveness (Erden, Klang, Sydler, & von Krogh, 2014). Montalban and 
Sakinç (2013) examined the effects of financialization and competition on productive 
models in pharmaceutical companies. Montalban and Sakinç found pharmaceutical 
companies’‎adaptations‎of‎blockbuster‎model‎maximized‎shareholder‎value,‎which‎
included financialization, technical change, product market regulations, and market 
competition. Montalban and Sakinç concluded that institutional investors are accelerators 
for‎transformational‎business‎models‎that‎must‎align‎with‎managers’‎controls‎and‎
practices during expansion strategy implementation as an effective business model for 
competitive advantage. Therefore, selecting business expansion model for pharmaceutical 
industries‎must‎align‎with‎managers’‎organizational‎competencies,‎external‎markets’‎
competitions,‎and‎stakeholders’‎demands. 
Business expansion models are part of the corporation strategy for growth and 
profit‎generation‎that‎leaders‎formulate‎by‎depending‎on‎the‎corporation’s‎components‎
and‎managers’‎motives,‎competences,‎understandings,‎and‎qualifications‎to‎achieve‎the‎
strategy targets (Martin, 2014). Enterprise managerial levels are important formulators of 
the appropriate expansion strategy and method of implementation, which decision 
making‎ process involved (Chen, Liu, Ni, & Wu, 2015). Chen et al. (2015) examined the 
relationship between strategic intent and external business factors affecting expansion 
strategy. Chen et al. found a significant relationship between the variables and posited 
that expansion strategy and decision making‎ processes must align with intentional and 
organizational capacities to achieve successful expansion strategy implementation. 
Therefore, expansion strategy includes multiple factors of the decision making‎ process 
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that leaders and managers must acquire to select the appropriate expansion strategy 
within or outside the business constructs of the organization. 
Applications to Professional Practice 
The‎application‎of‎leader’s‎adaptability‎to‎change,‎financial‎capacity‎and‎stability,‎
stakeholders’‎business‎awareness,‎and‎managers’‎engagement‎and knowledge are 
relevant to the professional business practices. Pharmaceutical leader’s expansion 
strategies include introductions of changes in the acquired systems to align capacities 
(Daems et al., 2014). The capacities alignment of the changes, financings, businesses, 
stakeholders, and managers are critical practices for implementing successful expansion 
strategy to achieve commercialization targets. 
The findings from this study are of value to business because leaders of strategy 
designers in pharmaceutical organizations need to account for the sustainability, 
potentials, and capacities to provide valid and reliable expansion strategies. Business 
expansion models are part of the corporation strategy for growth and profit generation 
that leaders formulate‎by‎depending‎on‎the‎corporation’s‎components‎and‎managers’‎
motives, competences, understandings, and qualifications to achieve the strategy targets 
(Martin, 2014). The findings from this study are developments and combinations of the 
conceptual framework applied from transformational‎leadership‎theory‎and‎stakeholders’‎
theory that included explorations of effective application of the expansion strategy for 




and stakeholders benefits from the organization activities to achieve the competitive 
advantage. 
The application of purposeful sample in this study included CEOs and managers 
from the Jordanian generic pharmaceutical companies. All participants, worked for more 
than 10 years in the expansion strategy for the organization. The findings from the 
semistructured interviews, documents reviews, and member checking confirmation 
included an appropriate foundation for business consideration of expansion strategy that 
involve‎adaptability‎to‎change,‎financial‎capacity‎and‎stability,‎stakeholders’‎business‎
awareness,‎and‎managers’‎engagement‎and‎knowledge.‎ 
Leader adaptability to change is institutional in organizational formation and 
business advancement practices (Filiou & Golesorkhi, 2014). Relationship between the 
internal organizational changes requirement for development and the gaining from 
expansion strategy that the partnering, outsourcing, regulatory attainment or knowledge 
sharing implied during the process implementation is critical for adaptability to change 
practices (Bellamy, Ghosh, & Hora, 2014). Therefore, awareness for adaptability to 
change is critical for leaders and managers during the implementation of the expansion 
strategy. 
Financial capacity and stability is a critical application for the expansion strategy 
practices. Shareholders, investors, and stockholders are business value accouters for the 
organizations’‎activities and performances. Expansion strategy includes ROI and sales 
revenues from markets. The effective application of the capital or cash flow, financing 
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strategies, and expense control are requirements for business practices for the expansion 
strategy.  
The‎professional‎participants‎in‎this‎study‎indicated‎for‎the‎stakeholders’‎business‎
awareness importance. The awareness of the organization activities from stakeholders 
includes the utilization of corporate transparency practices to achieve internal capacities 
development requirements and external capacities market access that involved expansion 
strategies (Tripathy & Prajapati, 2014). Pharmaceutical industries constitute of divers, 
integrate objective, and interactive systems in complex changing business and scientific 
climate (Nagurney, Li, & Nagurney, 2013).  
The scientific nature of the pharmaceutical industries and knowledge base 
formation including the high impact on the lives of the intended consumers guided the 
international healthcare organizations‎to‎regulate‎the‎pharmaceutical‎companies’‎
activities through enforcing GMP (Frau, Font Pous, Luppino, & Conforti, 2010). These 
regulations‎are‎for‎controlling‎and‎inspecting‎the‎systems’‎operations‎as‎an‎integral‎part‎
of the market authorization requirements (Yadav, 2013). The registration of dossiers and 
the time the research and development included are factors for awareness of the long-
term investments. Therefore, awareness is functional business processes for developing 
mutual understandings for the sustainable organization in competitive business markets 
(Men, 2014). 
Participants in this study worked for more than 10 years in expansion strategies. 
Form the conducted interviews the‎theme‎of‎managers’‎engagement‎and‎knowledge‎





managers acquired from experiences, education, skills, and exposures. Leaders’‎
encouragements‎and‎motivations‎include‎employees’‎engagements‎in‎sharing‎change‎
management benefits and valuing performances (Güntert, 2015). Therefore, business 
application‎of‎the‎managers’‎engagement‎and knowledge is important for leaders to 
develop‎the‎structural‎strategy‎formulator’s‎knowledge‎that‎leaders‎required‎from‎the‎
managers for implementing the expansion strategy.  
Implications for Social Change 
Pharmaceutical industries are scientific knowledge base industries that include 
scientific‎discoveries,‎market‎preferences,‎regions’‎demands,‎and‎epidemics‎fighting‎
within the business construct to achieve social and economic targets (Belderbos, Gilsing, 
& Suzuki, 2015). Generic pharmaceutical industries in the middle-income regions of 
MENA‎provided‎solutions‎for‎the‎pharmaceutical’s‎availability,‎in‎which‎effective‎
strategies‎implementation‎for‎the‎pharmaceutical’s‎business‎expansion‎contributed‎to‎
profits generation in the targeted MENA regions (Cameron et al., 2012). In 2013, generic 
pharmaceutical business leaders failed to ‎develop a business expansion strategy to satisfy 
demands of $26.2 billion supplies of ‎essential medicines for developing countries in the 
MENA communities (UN Millennium ‎Development Goals, 2014). These communities 
are potential stakeholders who could gain benefits by increasing generic medical supplies 
thereby‎meeting‎both‎physicians‎and‎patients’‎needs‎for‎increasing‎availability‎and‎
decreasing costs of generic pharmaceuticals to fight diseases. 
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Fighting diseases is a major implication for social change in this study. The 
generic pharmaceutical manufacturers’‎leaders in the MENA may apply the findings in 
this study of leader’s‎adaptability‎to‎change,‎financial‎capacity‎and‎stability,‎
stakeholders’‎business‎awareness,‎and‎managers’‎engagement‎and‎knowledge.‎The‎
application of the findings from this study may respond to the UN 
Millennium ‎Development Goals (2014) for fighting disease with generic essential 
medication that can save the lives in low-income regions in MENA and respond to the 
implementation of the expansion strategy. The expectations from the findings application 
are to provide the generic pharmaceutical leaders and managers with increased 
capabilities for catalyzing beneficial social changes by capacity expansion strategies. The 
subsequent expansion could provide adequate, affordable, and accessible medications for 
effecting social change in the remote MENA communities. 
Organizations with expansion strategies for social change are benefiting from the 
inclusion of social changes in vision and mission statements that guided the leaders, 
managers, and employees performances. Shareholders and leaders are interested in 
promoting‎the‎social‎changes‎that‎the‎companies’‎expansion‎strategies‎include‎through‎
integrated sustainability initiatives (Alakent & Ozer, 2014). Franks et al. (2014) 
recognized expansion strategies including corporate-cultural‎social‎changes’‎intentions as 
an advancement of corporate sustainability. The findings from this study are applicable 
for the alignments of the social change statements in the vision and mission statements of 
the organizations for the increasing interactions between communities and organizations. 
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Recommendations for Action 
The purpose of this qualitative descriptive multiple case study was to explore 
effective application of expansion strategy among Jordanian pharmaceutical managers ‎to 
satisfy the demand in the MENA markets. Generic pharmaceutical manufacturers in 
MENA region could apply the findings from this study to benefit from the effective 
application of the expansion strategy implementation. Organizations in MENA with 
expansion strategy focus may benefit from the findings of this study because 
implementations of the expansion strategy involve similar requirements for the business 
models. The steps for useful action of the findings from this study may include the 
following recommendations. 
Recommendation 1 is for development of the business awareness between the 
stakeholders‎of‎the‎organizations.‎Leaders’‎ability‎to‎change‎is‎the‎development‎of‎the‎
awareness‎of‎the‎business‎changes‎and‎external‎factors‎that‎affect‎the‎organization’s‎
activities. MENA region according to participants is changing with the economic 
instability and currencies devaluations. Therefore, leaders adapting changes with 
introduction of collaborations, business-to-business, or licensing is an option for 
expansions, which mitigate risks and develop relationships (Bellamy et al., 2014). 
Managers in pharmaceutical industries are developing knowledge, skills from 
scientific backgrounds, and experiences of the fields of the industry because of the 
regulatory codes for the management qualification for‎“safe,‎pure,‎and‎effective”‎
pharmaceutical‎products’‎manufacturing (FDA, 2001). Recommendation 2 is for 
pharmaceutical managers who must acquire business knowledge according to participants 
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in this study. Participants in this study mentioned the benefits of business training, 
business courses, and business educations including the technical scientific knowledge 
for implementing successful expansion strategies in the organizations.  
Recommendation 3 is for the educational institutions, associations, and trainers 
for pharmaceutical and scientific courses who may benefit from the findings of this study. 
The inclusion of practical courses for business education for pharmacy, engineering, 
chemistry, or biology courses will increase the business awareness of the scientific 
activities in universities and research departments in the pharmacy fields. Participants in 
this study were from scientific background and stressed for the importance of business 
awareness among stakeholders of the pharmaceutical industries.  
Recommendation 4 is for leaders to involve shareholders in the requirements for 
log-term investments with clear feasibility studies and business plans for critical funds 
approvals, according to the participants in this study. For the expansion strategy 
implementation, resources are critical factor for the executions (Casado & Peláez, 2014). 
The‎resources‎acquirements‎are‎shareholders’‎responsibility‎for‎approvals (Teirlinck & 
Spithoven, 2013). Therefore, managers must provide and build adequate studies and trust 
to gain approvals for the investments from the shareholders. 
The findings from this study may interest pharmaceutical and industrial leaders 
including‎healthcare‎organizations‎and‎healthcare‎educational‎systems’‎leaders.‎The‎
MENA pharmaceutical manufacturers associations may gain benefits from the findings in 
this study. In addition, managers in healthcare services and industries may find benefits 
form the finding in this study. The four themes emerged from this study and the four 
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recommendations are offering applicable practices for organizations with similar 
structures of the generic pharmaceutical industries. 
My intention is to disseminate the finding form this study in local conferences for 
the pharmaceutical manufacturers. The Jordanian association of pharmaceutical 
manufacturers (JAPM) is a professional’s local association, which I intend to submit the 
findings of this study for publishing. I plan to publish an article about the finding of this 
study in peer-reviewed journals like Journal of Health Economics, Industrial Marketing 
Management, or International Business Research. I will prepare a presentation for the 
findings from this study for Jordanian pharmaceutical manufactures who participated in 
this study for organizational training seminars. 
Recommendations for Further Research 
This qualitative multiple case study included sample form Jordanian 
pharmaceutical companies who practiced the expansion strategy in MENA region for 
more than 10 years. The participants in this study shared some ideas according to 
question 12 , which included recommendations for further research. The 
recommendations for further research may include the exploration of the business efforts 
for compliances in MENA regulations for pharmaceuticals registration and marketing and 
the cost of the replications encountered because of fragmented requirements. 
Quantitative researchers may conduct further research on the relationships 
between the themes emerged from this study. I recommend the further quantitative 
research‎about‎the‎relationship‎between‎the‎managers’‎competence‎in‎expansion‎strategy‎
and the financial performances for the generic pharmaceutical companies in MENA. In 
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addition, further quantitative researchers may study the relationship between 
shareholders’‎awareness‎of‎the‎expansion‎strategy‎effectiveness‎and‎managers’ 
engagements and knowledge about the expansion strategy. 
The limitations of the qualitative case study include the small sample size 
involved in the study (Ercikan & Roth, 2014). Therefore, further research may include 
larger sample size. In addition, the geographical boundaries in this case study design 
included limitations for Jordanian pharmaceutical companies, therefore, I recommend 
further research that include firms from MENA pharmaceutical companies. One 
limitation of this study include the exploration of pharmaceutical industries in Jordan, I 
recommend further research to include other similar industries with expansion strategy 
practices for the MENA region. 
Reflections 
In reflection of the DBA study program, I learned many academicals values and 
requirements for conducting research studies, particularly, during this research study. The 
new information I learned by practicing research methods included changes in my 
perceptions for the values of the research and researchers. The complexity of the 
interpretations that researches must view and keep the focus on the research topic was a 
new learning practice for me in this research study. Patience is a critical factor for the 
researchers that I learned from this study. Visiting the offices of the participants, calling 
for interview appointments, and the perceived intention of different participants was 
additional learning for me about the confidence of the successful implementers of the 
expansion strategy, who accepted and appreciated participation. 
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In my role as a researcher, I was able to keep my focus on the research topic and 
avoid any personal bias or preconceived information. I asked the interview questions and 
in some cases, I asked further questions to confirm my understanding of the answers or 
clarify the interpretation. I applied the member checking process to confirm my 
interpretation of the answers before starting the data analysis process. 
My respect to research and researchers increased after conducting this study. I 
was able to learn from the literature review, which I conducted for this research, but I 
confirmed the learned topics with practicing. I now have a new approach to confirm and 
judge facts not opinions. I practiced effective listening to participants with great respect, 
by avoiding interruption and keeping the focus on the answers. My thinking of the 
emerged themes from this study changed the way that I used to think about the practices 
of managers in pharmaceutical industries. The managers participated in this study were 
from different backgrounds, educational fields, and accountability levels in the 
organizations’‎hierarchy.‎The‎emerged‎themes‎from‎the‎answers‎of‎the‎managers’‎
participants included changes‎in‎my‎views‎to‎the‎managers’‎qualifications‎and 
competences for the pharmaceutical field. These requirements ignored or granted 
managers knowledge about basics of business.     
Conclusion 
Successful expansion strategy implementation is a characterization for the 
qualified implementers of the strategy. The qualification of the implementers of the 
expansion strategy includes the contributions of multiple advancements and 
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developments of the stakeholders of the organization. The knowledge awareness and 
distributions is critical for the successful implementations of the expansion strategy. 
The purpose of this qualitative descriptive multiple case study was to explore 
effective application of expansion strategy among Jordanian pharmaceutical managers ‎to 
satisfy the demand in the MENA markets. I collected data from interviews with CEOs 
and managers from generic pharmaceutical companies in Jordan who practiced and 
succeeded in applying expansion strategies in the MENA region and reviewed documents 
of financial statements for the data triangulation. I selected participants purposely from 
the Jordanian pharmaceutical managers with the professional application of expansion 
strategies in MENA markets. I applied member-checking process for the validity of the 
research. I reached the data saturation after I received no new information and the data 
were repetitive. I defined the data saturation point after conducting the seventh 
participant’s‎interview. 
The‎four‎themes‎emerged‎from‎the‎data‎analysis‎for‎this‎study‎were‎(a)‎leader’s‎
adaptability to change, (b) financial‎capacity‎and‎stability,‎(c)‎stakeholders’‎business‎
awareness,‎and‎(d)‎managers’‎engagement‎and‎knowledge.‎I‎confirmed‎the‎themes‎
emerged with the literature I reviewed in this study and the existing body of knowledge. I 
included the linking between the emerged themes and the conceptual framework of this 
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Appendix B: List of Interview Questions 
1. What strategies do you use for expanding generic pharmaceutical capacity for the 
MENA customers? 
2. What challenges did or do you face in implementing the business expansion 
strategies for this organization? 
3. What are core business processes that improve expansion strategy in this 
organization? 
4. What are the principal barriers you faced or are facing in implementing the 
expansion strategy? 
5. How do you communicate and address the barriers with subordinates working in 
expansion strategy?  
6. How did or do you address the principal barriers solutions or overcome in your 
expansion strategy? 
7. How do you evaluate expansion strategies implementations? 
8. What‎are‎managers’‎contributions‎to‎expansion‎strategies? 
9. How‎are‎managers’‎capabilities‎supporting‎expansion‎strategies‎in‎MENA‎region? 
10. What are supports you needed or need from shareholders to address the expansion 
strategy? 
11. How do you align the expansion strategy with the production capacity design? 
12. What are other information you might share about your development and 




Appendix C: Mindjet Map of the Relationships between the Themes
 
